MCID: CHN002
MIFTS: 41

Chancroid

Categories: Infectious diseases, Rare diseases, Skin diseases

Aliases & Classifications for Chancroid

MalaCards integrated aliases for Chancroid:

Name: Chancroid 12 74 52 54 43 15 32
Ulcus Molle, Skin 12
Chancroids 71

Classifications:



External Ids:

Disease Ontology 12 DOID:13778
ICD9CM 34 099.0
MeSH 43 D002602
SNOMED-CT 67 87429008
ICD10 32 A57
UMLS 71 C0007947

Summaries for Chancroid

NIH Rare Diseases : 52 Chancroid is a bacterial infection that is spread through sexual contact. It is caused by a type of bacteria called Haemophilus ducreyi . Chancroid is characterized by a small bump on the genital which becomes a painful ulcer. Men may have just one ulcer, but women often develop four or more. About half of the people who are infected with a chancroid will develop enlarged inguinal lymph nodes , the nodes located in the fold between the leg and the lower abdomen. In some cases, the nodes will break through the skin and cause draining abscesses . The swollen lymph nodes and abscesses are often called buboes. Chancroid infections can be treated with antibiotics , including azithromycin , ceftriaxone , ciprofloxacin , and erythromycin . Large lymph node swellings need to be drained, either with a needle or local surgery.

MalaCards based summary : Chancroid, also known as ulcus molle, skin, is related to primary syphilis and syphilis. An important gene associated with Chancroid is CCR6 (C-C Motif Chemokine Receptor 6), and among its related pathways/superpathways are Integrin Pathway and Akt Signaling. The drugs Acyclovir and Anti-Infective Agents have been mentioned in the context of this disorder. Affiliated tissues include skin, lymph node and testes, and related phenotypes are hematopoietic system and immune system

Disease Ontology : 12 A primary bacterial infectious disease that is a sexually transmitted infection located in skin of the genitals, has material basis in Haemophilus ducreyi, which is transmitted by sexual contact. The infection has symptom painful and soft ulcers.

Wikipedia : 74 Chancroid (/'?a?kr??d/ SHANG-kroyd) is a bacterial sexually transmitted infection characterized by... more...

Related Diseases for Chancroid

Diseases related to Chancroid via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 261, show less)
# Related Disease Score Top Affiliating Genes
1 primary syphilis 31.0 CD40LG CD4
2 syphilis 30.8 CD40LG CD4 CCR6 CCR5
3 bacterial infectious disease 30.1 HSPD1 CD40LG CD4 CCR6
4 immune deficiency disease 29.8 CD40LG CD4 CCR6 CCR5
5 lymphogranuloma venereum 10.7
6 granuloma inguinale 10.7
7 herpes simplex 10.6
8 genital herpes 10.6
9 chronic graft versus host disease 10.5 CD4 CD36
10 suppurative lymphadenitis 10.5 CD4 CCR6
11 spongiotic dermatitis 10.5 CD4 CCR6
12 anti-basement membrane glomerulonephritis 10.5 CD4 CCR6
13 farmer's lung 10.4 CD4 CD36
14 mikulicz disease 10.4 CD4 CCR6
15 esophageal candidiasis 10.4 CD4 CCR6
16 pneumonic tularemia 10.4 CD4 CCR6
17 mycobacterium gordonae 10.4 HSPD1 DLAT
18 autoimmune disease of cardiovascular system 10.4 CD4 CCR6
19 human immunodeficiency virus type 1 10.4
20 chlamydia 10.4
21 bacillary angiomatosis 10.4 HSPD1 CD4
22 opportunistic bacterial infectious disease 10.4 HSPD1 CD4
23 dacryoadenitis 10.4 CD4 CCR6
24 nocardiosis 10.4 HSPD1 CD4
25 hyper ige recurrent infection syndrome 1 10.4 CD4 CCR6
26 autoimmune vasculitis 10.4 CD4 CCR6
27 human monocytic ehrlichiosis 10.4 HSPD1 CD4
28 lymphadenitis 10.4
29 tuberculoid leprosy 10.4 CD4 CCR6
30 oral tuberculosis 10.4 WT1 CD4
31 vulvovaginitis 10.3 HSPD1 CCR6
32 interstitial keratitis 10.3 CD40LG CD36
33 riedel's fibrosing thyroiditis 10.3 CD40LG CD4
34 haemophilus influenzae 10.3
35 dermatophytosis 10.3 CD4 CCR6
36 cork-handlers' disease 10.3 CD40LG CD4
37 mucormycosis 10.3 CD4 CCR6
38 syphilitic meningitis 10.3 CD40LG CD4
39 early yaws 10.3 CD40LG CD4
40 latent syphilis 10.3 CD40LG CD4
41 gastroduodenitis 10.3 CD40LG CD4
42 duodenitis 10.3 CD40LG CD4
43 asymptomatic neurosyphilis 10.3 CD40LG CD4
44 macs syndrome 10.3 HSPD1 CD4
45 chronic conjunctivitis 10.3 CD4 CCR6
46 tertiary neurosyphilis 10.3 CD40LG CD4
47 transient arthritis 10.3 CD40LG CD4
48 norwegian scabies 10.3 CD40LG CD4
49 neuroretinitis 10.3 CD40LG CD4
50 meningovascular neurosyphilis 10.3 CD40LG CD4
51 optic papillitis 10.3 CD40LG CD4
52 viral exanthem 10.3 CD40LG CD4
53 tertiary syphilis 10.3 CD40LG CD4
54 acute retinal necrosis syndrome 10.3 CD40LG CD4
55 tick infestation 10.3 HSPD1 CD4
56 granulomatous hepatitis 10.3 CD40LG CD4
57 pustulosis palmaris et plantaris 10.3 CD40LG CCR6
58 cerebral lymphoma 10.3 CD40LG CD4
59 gastrointestinal tuberculosis 10.3 CD40LG CD4
60 abacavir allergy 10.3 CD4 CCR5
61 congenital syphilis 10.3 CD40LG CD4
62 mononeuritis of upper limb and mononeuritis multiplex 10.3 CD40LG CD4
63 mononeuritis multiplex 10.2 CD40LG CD4
64 cerebritis 10.2 CD40LG CD4
65 parotid disease 10.2 CD40LG CD4
66 exanthema subitum 10.2 CD40LG CD4
67 japanese spotted fever 10.2 HSPD1 CD40LG
68 trichinosis 10.2 CD40LG CD4
69 granulomatous dermatitis 10.2 CD40LG CD4
70 secondary syphilis 10.2 CD40LG CD4
71 splenic sequestration 10.2 CD40LG CD4
72 abdominal tuberculosis 10.2 CD40LG CD4
73 inclusion conjunctivitis 10.2 HSPD1 CD40LG
74 pityriasis rosea 10.2 CD40LG CD4
75 autoimmune neuropathy 10.2 CD40LG CD4
76 lung abscess 10.2 CD40LG CD4
77 adenoid hypertrophy 10.2 CD40LG CD4
78 sporotrichosis 10.2 CD40LG CD4
79 uveoparotid fever 10.2 CD40LG CD4
80 chronic meningitis 10.2 CD40LG CD4
81 parotitis 10.2 CD40LG CD4
82 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.2
83 good syndrome 10.2 CD40LG CD4
84 mite infestation 10.2 CD40LG CD4
85 monkeypox 10.2 CD40LG CD4
86 t-cell adult acute lymphocytic leukemia 10.2 CD4 CCR6
87 polyclonal hypergammaglobulinemia 10.2 CD40LG CD4
88 hairy tongue 10.2 CD40LG CD4
89 cervical adenitis 10.2 HSPD1 CD40LG
90 xerophthalmia 10.2 CD40LG CD4
91 miliary tuberculosis 10.2 CD40LG CD4
92 rocky mountain spotted fever 10.2 HSPD1 CD40LG
93 chorioretinitis 10.2 CD40LG CD4
94 cranial nerve palsy 10.2 CD40LG CD4
95 pleural empyema 10.2 CD40LG CD4
96 babesiosis 10.2 CD40LG CD36
97 choroiditis 10.2 CD40LG CD4
98 salpingitis 10.2 HSPD1 CD40LG
99 iridocyclitis 10.2 CD40LG CD4
100 fungal meningitis 10.2 CD40LG CD4
101 autoimmune disease of peripheral nervous system 10.1 CD40LG CD4
102 taeniasis 10.1 CD40LG CD4
103 blastomycosis 10.1 CD40LG CD4 CCR6
104 scleral disease 10.1 CD40LG CD4 CCR6
105 iritis 10.1 CD40LG CD4 CCR6
106 vaginal discharge 10.1 CD40LG CD4
107 central nervous system vasculitis 10.1 CD40LG CD4 CCR6
108 acute proliferative glomerulonephritis 10.1 CD40LG CD4 CCR6
109 coccidioidomycosis 10.1 CD40LG CD4 CCR6
110 thrombocytopenia due to platelet alloimmunization 10.1 CD40LG CD4 CCR6
111 childhood type dermatomyositis 10.1 CD40LG CD4 CCR6
112 autoimmune disease of skin and connective tissue 10.1 CD40LG CD4 CCR6
113 primary thrombocytopenia 10.1 CD40LG CD4 CCR6
114 keratoconjunctivitis sicca 10.1 CD40LG CD4 CCR6
115 epididymis disease 10.1 CD40LG CD4
116 lichen disease 10.1 CD40LG CD4 CCR6
117 histoplasmosis 10.1 CD40LG CD4 CCR6
118 t cell deficiency 10.1 CD40LG CD4 CCR6
119 cervicitis 10.1 HSPD1 CD4
120 autoimmune disease of blood 10.1 CD40LG CD4 CCR6
121 immunoglobulin alpha deficiency 10.1 CD40LG CD4 CCR6
122 plasma protein metabolism disease 10.1 CD40LG CD4 CCR6
123 ocular toxoplasmosis 10.1 CD40LG CCR5
124 lacrimal apparatus disease 10.1 CD40LG CD4 CCR6
125 panuveitis 10.1 CD40LG CD4 CCR6
126 vaginal disease 10.1 CD4 CCR6 CCR5
127 herpangina 10.1 CD40LG CD4 CCR6
128 chickenpox 10.1 CD40LG CD4 CCR6
129 splenic disease 10.1 CD40LG CD4 CCR6
130 bullous skin disease 10.1 CD40LG CD4 CCR6
131 middle ear disease 10.1 CD40LG CD4 CCR6
132 progressive multifocal leukoencephalopathy 10.1 CD40LG CD4 CCR6
133 anus disease 10.1 CD4 CCR6 CCR5
134 conjunctival disease 10.1 CD40LG CD4 CCR6
135 coccidiosis 10.1 CD40LG CD4 CCR6
136 dysentery 10.1 CD40LG CD4 CCR6
137 viral encephalitis 10.1 CD40LG CD4 CCR6
138 thymus gland disease 10.1 CD40LG CD4 CCR6
139 autoimmune disease of endocrine system 10.1 CD40LG CD4 CCR6
140 thymus cancer 10.1 CD40LG CD4 CCR6
141 opportunistic mycosis 10.1 CD40LG CD4 CCR6
142 paranasal sinus disease 10.1 CD40LG CD4 CCR6
143 meningoencephalitis 10.1 CD40LG CD4 CCR6
144 thrombocytopenic purpura, autoimmune 10.1 CD40LG CD4 CCR6
145 cellulitis 10.1 CD40LG CD4 CCR6
146 spinal cord disease 10.1 CD40LG CD4 CCR6
147 b cell deficiency 10.1 CD40LG CD4 CCR6
148 combined t cell and b cell immunodeficiency 10.1 CD40LG CD4 CCR6
149 neuromuscular junction disease 10.1 CD40LG CD4 CCR6
150 nose disease 10.1 CD40LG CD4 CCR6
151 acute cystitis 10.1 CD40LG CD4 CCR6
152 exanthem 10.1 CD40LG CD4 CCR6
153 salivary gland disease 10.1 CD40LG CD4 CCR6
154 autoimmune disease of gastrointestinal tract 10.1 CD40LG CD4 CCR6
155 extrinsic cardiomyopathy 10.1 CD40LG CD4 CCR6
156 hypersensitivity reaction type iv disease 10.1 CD40LG CD4 CCR6
157 parasitic helminthiasis infectious disease 10.1 CD40LG CD4 CCR6
158 lymphatic system cancer 10.1 CD40LG CD4 CCR6
159 temporal arteritis 10.1 CD40LG CD4 CCR6
160 cranial nerve disease 10.1 CD40LG CD4 CCR6
161 collagen disease 10.1 CD40LG CD4 CCR6
162 bacterial pneumonia 10.1 CD40LG CD4 CCR6
163 mature b-cell neoplasm 10.1 CD40LG CD4 CCR6
164 hair disease 10.1 CD40LG CD4 CCR6
165 blood coagulation disease 10.1 CD40LG CD4 CCR6
166 lymphatic system disease 10.1 CD40LG CD4 CCR6
167 autoimmune disease of musculoskeletal system 10.1 CD40LG CD4 CCR6
168 bronchial disease 10.1 CD40LG CD4 CCR6
169 orchitis 10.1 CD40LG CD4
170 acute disseminated encephalomyelitis 10.1 HSPD1 CD40LG CCR6
171 x-linked recessive disease 10.1 CD40LG CD4 CCR6
172 autoimmune disease of central nervous system 10.1 CD40LG CD4 CCR6
173 bone marrow cancer 10.1 CD40LG CD4 CCR6
174 west nile fever 10.1 CD40LG CCR5
175 x-linked monogenic disease 10.1 CD40LG CD4 CCR6
176 pfeiffer syndrome 10.1 CD40LG CD4 CCR6
177 optic nerve disease 10.1 CD40LG CD4 CCR6
178 alcohol dependence 10.1
179 gastrointestinal ulceration, recurrent, with dysfunctional platelets 10.1
180 neutropenia 10.1
181 bacterial vaginosis 10.1
182 paraphimosis 10.1
183 periodontitis 10.1
184 vasculitis 10.1
185 molluscum contagiosum 10.1
186 lipogranulomatosis 10.1
187 bone inflammation disease 10.1 CD40LG CD4 CCR6
188 bell's palsy 10.1 CD40LG CD4
189 reactive arthritis 10.1 HSPD1 CCR6 CCR5
190 biliary tract disease 10.1 DLAT CD40LG CCR6
191 cat-scratch disease 10.1 HSPD1 CD40LG CD4
192 spondyloarthropathy 1 10.1 HSPD1 CD40LG CCR6
193 bartonellosis 10.1 HSPD1 CD40LG CD4
194 upper respiratory tract disease 10.1 CD40LG CD4 CCR6
195 chlamydia pneumonia 10.1 HSPD1 CD40LG CD4
196 urethritis 10.0 HSPD1 CD40LG CD4
197 tularemia 10.0 HSPD1 CD40LG CD4
198 hantavirus hemorrhagic fever with renal syndrome 10.0 CD40LG CD4
199 ehrlichiosis 10.0 HSPD1 CD40LG CD4
200 endocardium disease 10.0 HSPD1 CD40LG CD4
201 strongyloidiasis 10.0 CD40LG CD4
202 allergic contact dermatitis 10.0 CD4 CCR10 CCL27
203 epidemic typhus 10.0 HSPD1 CD40LG CD4
204 contact dermatitis 10.0 CD4 CCR10 CCL27
205 immunodeficiency with hyper-igm, type 3 10.0 CD40LG CD4
206 kawasaki disease 10.0 HSPD1 CD40LG CD4
207 leukocyte disease 10.0 CD40LG CD4 CCR6
208 human immunodeficiency virus infectious disease 10.0 CD4 CCR6 CCR5
209 systemic scleroderma 10.0 CD40LG CD4 CCR6
210 papilledema 10.0 CD40LG CD4
211 immune system disease 9.9 CD40LG CD4 CCR6
212 blood platelet disease 9.9 CD40LG CD4 CD36 CCR6
213 yellow fever 9.9 CD40LG CCR6 CCR5
214 west nile encephalitis 9.9 CD40LG CD4 CCR5
215 thrombasthenia 9.9 VTN CD36
216 trichomoniasis 9.9 CD40LG CD4 CCR5
217 demyelinating disease 9.9 CD40LG CD4 CCR6
218 facial paralysis 9.9 CD40LG CD4
219 o'nyong'nyong fever 9.9 VTN CD40LG
220 fallopian tube disease 9.9 CD40LG CD4 CCR5
221 immune-complex glomerulonephritis 9.9 CD40LG CD4 CCR5
222 cholangitis 9.9 DLAT CD40LG CCR5
223 herpes zoster 9.9 CD40LG CD4 CCR5
224 vaginitis 9.9 DLAT CD4 CCR6 CCR5
225 autoimmune disease of urogenital tract 9.9 DLAT CD40LG CD4 CCR6
226 bile duct disease 9.9 DLAT CD40LG CD4 CCR6
227 congenital toxoplasmosis 9.9 CD40LG CD4
228 primary systemic mycosis 9.9 HSPD1 CD40LG CD4 CCR6
229 lymph node disease 9.9 HSPD1 CD40LG CD4 CCR6
230 commensal bacterial infectious disease 9.9 HSPD1 CD40LG CD4 CCR6
231 testicular disease 9.9 HSPD1 CD40LG CD4 CCR6
232 leprosy 3 9.9 HSPD1 CD40LG CD4 CCR6
233 lymphoma, mucosa-associated lymphoid type 9.9 HSPD1 CD40LG CD4 CCR6
234 ileitis 9.9 CCR6 CCR5 ACKR2
235 autoimmune glomerulonephritis 9.8 CD4 CCR6
236 uveal disease 9.8 WT1 CD40LG CD4 CCR6
237 human granulocytic anaplasmosis 9.8 HSPD1 CD40LG
238 primary biliary cirrhosis 9.8 HSPD1 DLAT CD40LG CD4
239 sezary's disease 9.7 CD4 CCR6 CCR10 ACKR2
240 muscular disease 9.7 WT1 CD40LG CD4 CCR6
241 pneumocystosis 9.7 CD40LG CD4 CCR6 CCR5
242 rectal disease 9.7 CD40LG CD4 CCR6 CCR5
243 parasitic protozoa infectious disease 9.7 CD40LG CD4 CCR6 CCR5
244 granulomatosis with polyangiitis 9.7 CD40LG CD4 CCR6 CCR5
245 sarcoidosis 1 9.7 CD40LG CD4 CCR6 CCR5
246 acquired immunodeficiency syndrome 9.7 CD40LG CD4 CCR6 CCR5
247 viral infectious disease 9.7 CD40LG CD4 CCR6 CCR5
248 dermatitis, atopic 9.7 CD40LG CD4 CCR6 CCL27
249 connective tissue disease 9.7 HSPD1 CD40LG CD4 CD36 CCR6
250 celiac disease 1 9.6 CD40LG CD4 CCR6 ACKR2
251 rheumatic disease 9.6 VTN CD40LG CCR6
252 primary bacterial infectious disease 9.5 HSPD1 CD40LG CD4 CCR6 CCR5
253 behcet syndrome 9.5 HSPD1 CD40LG CD4 CCR6 CCR5
254 autoimmune disease 9.5 HSPD1 DLAT CD40LG CCR6 CCR5
255 diabetes mellitus, insulin-dependent 9.4 HSPD1 CD40LG CD4 CCR6 CCR5
256 myeloma, multiple 9.4 VTN CD40LG CD4 CCR6
257 cholangitis, primary sclerosing 9.4 DLAT CD40LG CD4 CCR6 ACKR2
258 rheumatoid arthritis 9.3 HSPD1 CD40LG CD4 CCR6 CCR5
259 vascular disease 9.3 VTN HSPD1 CD40LG CD4
260 skin disease 8.8 VTN CD40LG CD4 CCR6 CCR10 CCL27
261 multiple sclerosis 8.8 VTN HSPD1 CD40LG CD4 CCR6 CCR5

Graphical network of the top 20 diseases related to Chancroid:



Diseases related to Chancroid

Symptoms & Phenotypes for Chancroid

MGI Mouse Phenotypes related to Chancroid:

45 (showing 2, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.61 CCR10 CCR5 CCR6 CD36 CD4 CD40LG
2 immune system MP:0005387 9.28 ACKR2 CCR10 CCR5 CCR6 CD36 CD4

Drugs & Therapeutics for Chancroid

Drugs for Chancroid (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 3, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Acyclovir Approved Phase 2, Phase 3 59277-89-3 2022
2 Anti-Infective Agents Phase 2, Phase 3
3 Antiviral Agents Phase 2, Phase 3

Interventional clinical trials:

(showing 2, show less)
# Name Status NCT ID Phase Drugs
1 Impact of Episodic Acyclovir Therapy on Ulcer Duration and HIV Shedding From Genital Ulcers Among Men in South Africa Completed NCT00164424 Phase 2, Phase 3 Acyclovir
2 Anti-Herpetic Treatment Associated With Syndromic Management of Genital Ulcer in Africa: Clinical and Biological Evaluation on HIV-1 and HSV-2 Shedding (ANRS 1212) Completed NCT00158483 Phase 2 Acyclovir (ACV)

Search NIH Clinical Center for Chancroid

Inferred drug relations via UMLS 71 / NDF-RT 50 :


ERYTHROMYCIN PWDR

Cochrane evidence based reviews: chancroid

Genetic Tests for Chancroid

Anatomical Context for Chancroid

MalaCards organs/tissues related to Chancroid:

40
Skin, Lymph Node, Testes, T Cells, Cervix, Endothelial, Neutrophil

Publications for Chancroid

Articles related to Chancroid:

(showing 808, show less)
# Title Authors PMID Year
1
Characterization of Haemophilus ducreyi cdtA, cdtB, and cdtC mutants in in vitro and in vivo systems. 61 54
11500438 2001
2
Rollet's mixed chancre in Brazilian pregnant women: An unusual case report. 61
31743797 2019
3
Genital Ulcer Disease: A Review of Pathogenesis and Clinical Features. 61
31253050 2019
4
Nonviral Sexually Transmitted Diseases. 61
31507345 2019
5
A Class I Haemophilus ducreyi Strain Containing a Class II hgbA Allele Is Partially Attenuated in Humans: Implications for HgbA Vaccine Efficacy Trials. 61
31036601 2019
6
Determination of an Interaction Network between an Extracellular Bacterial Pathogen and the Human Host. 61
31213562 2019
7
Common Bacterial and Viral Infections: Review of Management in the Pregnant Patient. 61
30556401 2019
8
[Lentigines]. 61
31692707 2019
9
[Chancroid]. 61
31565145 2019
10
[Sexually Transmitted Infections in the Tropics]. 61
30324430 2018
11
First reported case of chancroid in the Czech Republic. 61
29749871 2018
12
Disease Pattern among Sexually Transmitted Infection Clinic Attendees: A Hospital-Based Study. 61
30504980 2018
13
From in vivo to in vitro: How the Guatemala STD Experiments Transformed Bodies Into Biospecimens. 61
29652094 2018
14
Putative vaccine candidates and drug targets identified by reverse vaccinology and subtractive genomics approaches to control Haemophilus ducreyi, the causative agent of chancroid. 61
29792307 2018
15
Direct Whole-Genome Sequencing of Cutaneous Strains of Haemophilus ducreyi. 61
29553314 2018
16
The Etiology of Genital Ulcer Disease and Coinfections With Chlamydia trachomatis and Neisseria gonorrhoeae in Zimbabwe: Results From the Zimbabwe STI Etiology Study. 61
29240636 2018
17
Despite Being "Known, Highly Promiscuous and Active": Presumed Heterosexuality in the USPHS's STD Inoculation Study, 1946-48. 61
30274528 2018
18
Macrolides for treatment of Haemophilus ducreyi infection in sexually active adults. 61
29226307 2017
19
Usefulness and Utility of NACO Regime in the Management of Sexually Transmitted Infections: A Pilot Study. 61
29263538 2017
20
Skin diseases of the vulva: Infectious diseases. 61
28397528 2017
21
Sexually Transmitted Infections in Melbourne, Australia from 1918 to 2016: nearly a century of data. 61
29720070 2017
22
Pseudoepitheliomatous hyperplasia causing a painful plaque in a HIV-infected female. 61
28470128 2017
23
2017 European guideline for the management of chancroid. 61
28081686 2017
24
Gonorrhoea in Greenland, incidence and previous preventive measures: a review to improve future strategies. 61
28745556 2017
25
Haemophilus ducreyi Cutaneous Ulcer Strains Diverged from Both Class I and Class II Genital Ulcer Strains: Implications for Epidemiological Studies. 61
28027326 2016
26
Sexually Transmitted Infections Among Hospitalized Patients With Human Immunodeficiency Virus Infection and Acquired Immune Deficiency Syndrome (HIV/AIDS) in Zahedan, Southeastern Iran. 61
27818966 2016
27
Sexually transmitted infections case notification rates in the Kingdom of Saudi Arabia, 2005-2012. 61
27580336 2016
28
Other sexually transmitted diseases chancroid and donovanosis. 61
27107782 2016
29
First case of chancroid in 14 years at the largest STI clinic in Paris, France. 61
26378189 2016
30
Complete Genome Sequences of 11 Haemophilus ducreyi Isolates from Children with Cutaneous Lesions in Vanuatu and Ghana. 61
27389258 2016
31
Haemophilus ducreyi Seeks Alternative Carbon Sources and Adapts to Nutrient Stress and Anaerobiosis during Experimental Infection of Human Volunteers. 61
26930707 2016
32
Haemophilus ducreyi: from sexually transmitted infection to skin ulcer pathogen. 61
26658654 2016
33
Prevalence of Sexually Transmitted Infection in Teenage Pregnancy in Rajavithi Hospital, Thailand. 61
27266230 2016
34
Medical Examination of Aliens--Revisions to Medical Screening Process. Final rule. 61
26812891 2016
35
Defining Potential Vaccine Targets of Haemophilus ducreyi Trimeric Autotransporter Adhesin DsrA. 61
25897604 2015
36
A case of syphilitic anal condylomata lata mimicking malignancy. 61
26555060 2015
37
[Male circumcision from an infectiological point of view]. 61
25492382 2015
38
Travel-related sexually transmitted infections. 61
26726895 2015
39
Molecular phylogenetic analysis of non-sexually transmitted strains of Haemophilus ducreyi. 61
25774793 2015
40
Male Circumcision and STI Acquisition in Britain: Evidence from a National Probability Sample Survey. 61
26083250 2015
41
Pattern of sexually transmitted infections in a Muslim majority region of North India. 61
26392651 2015
42
UK National Guideline for the management of Chancroid 2014. 61
25080286 2014
43
Haemophilus ducreyi RpoE and CpxRA appear to play distinct yet complementary roles in regulation of envelope-related functions. 61
25201944 2014
44
Syphilis and human experimentation from World War II to the present: a historical perspective and reflections on ethics. 61
24461955 2014
45
Pattern of sexually transmitted diseases in patients presenting at Ayub teaching hospital, Abbottabad. 61
25672192 2014
46
Chancroid - desperate patient makes own diagnosis. 61
24535694 2014
47
A (p)ppGpp-null mutant of Haemophilus ducreyi is partially attenuated in humans due to multiple conflicting phenotypes. 61
24914217 2014
48
Outer membrane protein P4 is not required for virulence in the human challenge model of Haemophilus ducreyi infection. 61
24961160 2014
49
Sexually transmitted infections. 61
24889293 2014
50
Epidemiology, clinical features, diagnosis and treatment of Haemophilus ducreyi - a disappearing pathogen? 61
24597521 2014
51
The Haemophilus ducreyi trimeric autotransporter adhesin DsrA protects against an experimental infection in the swine model of chancroid. 61
24844153 2014
52
Assessing the antibiotic potential of essential oils against Haemophilus ducreyi. 61
24885682 2014
53
Sexual transmission of human T-cell lymphotropic virus type 1. 61
25075475 2014
54
The Haemophilus ducreyi LspA1 protein inhibits phagocytosis by using a new mechanism involving activation of C-terminal Src kinase. 61
24902122 2014
55
Chancroid, lymphogranuloma venereum, granuloma inguinale, genital herpes simplex infection, and molluscum contagiosum. 61
24559566 2014
56
Haemophilus ducreyi Hfq contributes to virulence gene regulation as cells enter stationary phase. 61
24520065 2014
57
A clinico-epidemiological study of ulcerative sexually transmitted diseases with human immunodeficiency virus status. 61
24958991 2014
58
Virtual screening of phytochemicals to novel targets in Haemophilus ducreyi towards the treatment of Chancroid. 61
25258485 2014
59
Trimeric autotransporter DsrA is a major mediator of fibrinogen binding in Haemophilus ducreyi. 61
24042118 2013
60
Sexually transmitted diseases. 61
23958358 2013
61
Activation of CpxRA in Haemophilus ducreyi primarily inhibits the expression of its targets, including major virulence determinants. 61
23729647 2013
62
Haemophilus ducreyi infection induces activation of the NLRP3 inflammasome in nonpolarized but not in polarized human macrophages. 61
23753629 2013
63
[Anorectal manifestations of sexually transmitted infections]. 61
23798024 2013
64
Resveratrol is cidal to both classes of Haemophilus ducreyi. 61
23541304 2013
65
Carbon storage regulator A contributes to the virulence of Haemophilus ducreyi in humans by multiple mechanisms. 61
23230298 2013
66
Alteration in sample preparation to increase the yield of multiplex Polymerase Chain Reaction assay for diagnosis of genital ulcer disease. 61
23508423 2013
67
Sexually transmitted infections and male circumcision: a systematic review and meta-analysis. 61
23710368 2013
68
Genital Ulcer Disease: How Worrisome Is It Today? A Status Report from New Delhi, India. 61
26316954 2013
69
Prevalence and associations of genital ulcer and urethral pathogens in men presenting with genital ulcer syndrome to primary health care clinics in South Africa. 61
23064538 2012
70
Etiologic pattern of genital ulcers in Lusaka, Zambia: has chancroid been eliminated? 61
23001266 2012
71
Genital ulcer disease treatment for reducing sexual acquisition of HIV. 61
22895969 2012
72
Periodic presumptive treatment of curable sexually transmitted infections among sex workers: recent experience with implementation. 61
22156895 2012
73
Diagnosis and management of genital ulcers. 61
22335265 2012
74
The role of sexually transmitted infections in the evolution of the South African HIV epidemic. 61
22035250 2012
75
Sialylation of lipooligosaccharides is dispensable for the virulence of Haemophilus ducreyi in humans. 61
22144477 2012
76
In the wake of Guatemala: the case for voluntary compensation and remediation. 61
22390459 2012
77
Oral immunization using HgbA in a recombinant chancroid vaccine delivered by attenuated Salmonella typhimurium SL3261 in the temperature-dependent rabbit model. 61
22100216 2012
78
Chancroid transmission dynamics: a mathematical modeling approach. 61
21842439 2011
79
International human subject research: taking stock in the wake of the Guatemala affair. 61
21601011 2011
80
Trimethoprim/sulfametrole: evaluation of the available clinical and pharmacokinetic/pharmacodynamic evidence. 61
21741802 2011
81
Expression of the Flp proteins by Haemophilus ducreyi is necessary for virulence in human volunteers. 61
21939541 2011
82
Haemophilus ducreyi lipooligosaccharides induce expression of the immunosuppressive enzyme indoleamine 2,3-dioxygenase via type I interferons and tumor necrosis factor alpha in human dendritic cells. 61
21576329 2011
83
Identification and characterization of a heme periplasmic-binding protein in Haemophilus ducreyi. 61
21347851 2011
84
On the evolution of the sexually transmitted bacteria Haemophilus ducreyi and Klebsiella granulomatis. 61
22239475 2011
85
Passive immunization with a polyclonal antiserum to the hemoglobin receptor of Haemophilus ducreyi confers protection against a homologous challenge in the experimental swine model of chancroid. 61
21646451 2011
86
Chancroid in an HIV-negative woman in the Midwestern United States. 61
19926434 2011
87
Pattern of sexually transmitted infections in males in interior Sindh: a 10-year-study. 61
23272449 2011
88
Venereology in India. 61
21965840 2011
89
Rapid divergence of two classes of Haemophilus ducreyi. 61
21515774 2011
90
A Haemophilus ducreyi CpxR deletion mutant is virulent in human volunteers. 61
21606544 2011
91
Sexually transmitted infections in Pakistan. 61
21623055 2011
92
European guideline for the management of chancroid, 2011. 61
21571970 2011
93
Genital ulcer diseases among HIV-infected female commercial sex workers in Ibadan, Nigeria. 61
21834260 2011
94
Poverty, folate deficiency, human immunodeficiency virus and ulcerated vulval sexually transmitted diseases in Jamaica. 61
21942116 2011
95
Use of signature-tagged mutagenesis to identify virulence determinants in Haemophilus ducreyi responsible for ulcer formation. 61
21185881 2011
96
The effect of syndromic management interventions on the prevalence of sexually transmitted infections in South Africa. 61
21147454 2011
97
Episodic therapy for genital herpes in sub-saharan Africa: a pooled analysis from three randomized controlled trials. 61
21799914 2011
98
What have we learned from sexually transmitted infection research in sub-Saharan Africa? 61
21113067 2010
99
Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA with adjuvant monophosphoryl lipid A protects swine from a homologous but not a heterologous challenge. 61
20584974 2010
100
Detoxified Haemophilus ducreyi cytolethal distending toxin and induction of toxin specific antibodies in the genital tract. 61
20609397 2010
101
[Import and local transmission of Haemophilus ducreyi]. 61
20654280 2010
102
Role played by CD4+FOXP3+ regulatory T Cells in suppression of host responses to Haemophilus ducreyi during experimental infection of human volunteers. 61
20443736 2010
103
Chronic cutaneous ulcers secondary to Haemophilus ducreyi infection. 61
20230355 2010
104
Etiology of genital ulcer disease. A prospective study of 278 cases seen in an STD clinic in Paris. 61
19910862 2010
105
Host-pathogen interplay of Haemophilus ducreyi. 61
19918177 2010
106
Increased risk of genital ulcer disease in women during the first month after initiating antiretroviral therapy. 61
19648822 2009
107
Inactivation of the Haemophilus ducreyi luxS gene affects the virulence of this pathogen in human subjects. 61
19552526 2009
108
Trends of Sexually Transmitted Infections : A 33 Year Experience. 61
27408254 2009
109
An immunogenic, surface-exposed domain of Haemophilus ducreyi outer membrane protein HgbA is involved in hemoglobin binding. 61
19451245 2009
110
Experimental infection of human volunteers with Haemophilus ducreyi: fifteen years of clinical data and experience. 61
19432549 2009
111
A comparative study of single-dose treatment of chancroid using thiamphenicol versus Azithromycin. 61
20191200 2009
112
[Image of the month. Combined chancre, a soft chancroid and a syphilitic chancre]. 61
19514534 2009
113
Comparative proteomic analysis of the Haemophilus ducreyi porin-deficient mutant 35000HP::P2AB. 61
19103932 2009
114
Immunogenic and adjuvant properties of Haemophilus ducreyi lipooligosaccharides. 61
19397884 2009
115
Antibiotic use in sexually transmissible diseases. 61
18984368 2009
116
[Infectious pathology: vulvovaginitis, sexually transmitted diseases, pelvic inflammatory disease, tubo-ovarian abscesses]. 61
19436336 2009
117
[Trade, wars and the venereal disease: VD epidemic and control of Korea in the late nineteenth and early twentieth century]. 61
19174628 2008
118
In vivo virulence properties of bacterial cytolethal-distending toxin. 61
18489725 2008
119
Cytolethal distending toxin upregulates RANKL expression in Jurkat T-cells. 61
18754324 2008
120
Recent advances in management of genital ulcer disease and anogenital warts. 61
18564250 2008
121
Cutaneous chancroid in a visitor from Vanuatu. 61
18412810 2008
122
Outer membrane protein DsrA is the major fibronectin-binding determinant of Haemophilus ducreyi. 61
18212073 2008
123
Chancroid and human immunodeficiency virus infection--a review. 61
18173591 2008
124
Genital ulcerative disease and sexually transmitted urethritis and circumcision: a meta-analysis. 61
18073009 2007
125
Why circumcision is a biomedical imperative for the 21(st) century. 61
17935209 2007
126
Proposed second class of Haemophilus ducreyi strains show altered protein and lipooligosaccharide profiles. 61
17676659 2007
127
The Hd0053 gene of Haemophilus ducreyi encodes an alpha2,3-sialyltransferase. 61
17662691 2007
128
Understanding the differences between contrasting HIV epidemics in east and west Africa: results from a simulation model of the Four Cities Study. 61
17405781 2007
129
Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics. 61
17405782 2007
130
Trends in the use of sexually transmitted disease diagnostic technologies in California, 1996-2003. 61
17277611 2007
131
Clinical patterns of sexually transmitted diseases, associated sociodemographic characteristics, and sexual practices in the Farwaniya region of Kuwait. 61
17550558 2007
132
[Chancroid]. 61
17553398 2007
133
Haemophilus ducreyi causing chronic skin ulceration in children visiting Samoa. 61
17443459 2007
134
Experimental infection with Haemophilus ducreyi in persons who are infected with HIV does not cause local or augment systemic viral replication. 61
17436224 2007
135
Genital ulcers in women: clinical, microbiologic and histopathologic characteristics. 61
17625773 2007
136
Male circumcision as a preventive measure against HIV and other sexually transmitted diseases. 61
17197884 2007
137
Identification of genes involved in the expression of atypical lipooligosaccharide structures from a second class of Haemophilus ducreyi. 61
17030566 2007
138
Chancroid. 61
17151046 2006
139
Risk factors of herpes simplex virus type 2 among STD clinic attenders in Delhi, India. 61
17913210 2006
140
[Chancroid]. 61
17146895 2006
141
Changing trends in sexually transmitted infections at a Regional STD Centre in north India. 61
17213525 2006
142
The contribution of cytolethal distending toxin to bacterial pathogenesis. 61
17123907 2006
143
Empirical observations underestimate the proportion of human immunodeficiency virus infections attributable to sexually transmitted diseases in the Mwanza and Rakai sexually transmitted disease treatment trials: Simulation results. 61
16778738 2006
144
Binding of Haemophilus ducreyi to carbohydrate receptors is mediated by the 58.5-kDa GroEL heat shock protein. 61
16880000 2006
145
[Chancroid]. 61
17072169 2006
146
Localization of Haemophilus ducreyi in naturally acquired chancroidal ulcers. 61
16872858 2006
147
Expression of Haemophilus ducreyi collagen binding outer membrane protein NcaA is required for virulence in swine and human challenge models of chancroid. 61
16622201 2006
148
Detection and discrimination of herpes simplex viruses, Haemophilus ducreyi, Treponema pallidum, and Calymmatobacterium (Klebsiella) granulomatis from genital ulcers. 61
16619156 2006
149
Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid. 61
16552053 2006
150
Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and meta-analysis. 61
16581731 2006
151
Co-occurrence of chancroid and gonorrhea. 61
17241572 2006
152
Sexually transmitted infections in Saudi Arabia. 61
16403220 2006
153
Molecular characterization of Haemophilus ducreyi isolates from different geographical locations. 61
16390960 2006
154
Profile of men suffering from sexually transmitted infections in Pakistan. 61
16689488 2006
155
Haemophilus ducreyi targets Src family protein tyrosine kinases to inhibit phagocytic signaling. 61
16299270 2005
156
Changes in the etiology of sexually transmitted diseases in Botswana between 1993 and 2002: implications for the clinical management of genital ulcer disease. 61
16206106 2005
157
Identification of a novel sialic acid transporter in Haemophilus ducreyi. 61
16177350 2005
158
In vitro and in vivo activity of combination antimicrobial agents on Haemophilus ducreyi. 61
16046468 2005
159
Sentinel surveillance of sexually transmitted infections in South Africa: a review. 61
16061532 2005
160
Molecular diagnosis of lymphogranuloma venereum in patients with genital ulcer disease. 61
15956435 2005
161
Vaginitis and sexually transmitted infections in a hospital based study. 61
16045093 2005
162
Induction of apoptosis/necrosis in various human cell lineages by Haemophilus ducreyi cytolethal distending toxin. 61
15804526 2005
163
The cytolethal distending toxin of Haemophilus ducreyi aggravates dermal lesions in a rabbit model of chancroid. 61
15876546 2005
164
Treatment of chancroid in resource-poor countries. 61
15918786 2005
165
Attenuated Salmonella typhimurium SL3261 as a vaccine vector for recombinant antigen in rabbits. 61
15914198 2005
166
The laboratory diagnosis of Haemophilus ducreyi. 61
18159525 2005
167
Syphilis and gonorrhoea in the Czech Republic. 61
15677852 2004
168
Bacterial sexually transmitted diseases. 61
20011261 2004
169
Changing patterns of sexually transmitted infections in India. 61
15736552 2004
170
Selected sexually transmitted diseases and their relationship to HIV. 61
15596321 2004
171
Differential expression of porins OmpP2A and OmpP2B of Haemophilus ducreyi. 61
15501753 2004
172
Interactions of Haemophilus ducreyi and purified cytolethal distending toxin with human monocyte-derived dendritic cells, macrophages and CD4+ T cells. 61
15488736 2004
173
Expression of the LspA1 and LspA2 proteins by Haemophilus ducreyi is required for virulence in human volunteers. 61
15271912 2004
174
A novel lectin, DltA, is required for expression of a full serum resistance phenotype in Haemophilus ducreyi. 61
15155648 2004
175
A 16-year study of HIV seroprevalence and HIV-related diseases in a teaching tertiary care hospital in India. 61
15038864 2004
176
Diagnosis and Management of Chancroid in Nigeria. 61
27528984 2004
177
Unusual presentation of early lymphogranuloma venereum in an HIV-1 infected patient: effective treatment with 1 g azithromycin. 61
14663119 2003
178
A humoral immune response confers protection against Haemophilus ducreyi infection. 61
14638786 2003
179
Haemophilus ducreyi requires an intact flp gene cluster for virulence in humans. 61
14638812 2003
180
Incidence determinants of gonorrhea, chlamydial genital infection, syphilis and chancroid in attendees at a sexually transmitted disease clinic in Athens, Greece. 61
14636203 2003
181
Inhibition of phagocytosis by Haemophilus ducreyi requires expression of the LspA1 and LspA2 proteins. 61
14500520 2003
182
Specificity of antibodies directed against the cytolethal distending toxin of Haemophilus ducreyi in patients with chancroid. 61
12927521 2003
183
Genital ulcers in women. 61
12844451 2003
184
Sexually transmitted diseases (STDs)--a synoptic overview for urologists. 61
12814668 2003
185
Candida infection as a risk factor for HIV transmission. 61
12869296 2003
186
Increasing relative prevalence of HSV-2 infection among men with genital ulcers from a mining community in South Africa. 61
12794202 2003
187
Mutations in the lspA1 and lspA2 genes of Haemophilus ducreyi affect the virulence of this pathogen in an animal model system. 61
12704119 2003
188
Profile of men suffering from sexually transmitted infections in Pakistan. 61
14552241 2003
189
HIV prevalence in Zimbabwean women: 54-67% knowledge and perceived risk. 61
12665445 2003
190
CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking. 61
12406880 2003
191
Study of genital lesions. 61
17642854 2003
192
Chancroid: contemporary appraisal. 61
12653911 2003
193
[Image of the month. Chancroid]. 61
12693303 2003
194
Chancroid: clinical manifestations, diagnosis, and management. 61
12576620 2003
195
[Principles for the control of sexually transmitted infections in tropical areas]. 61
15015842 2003
196
[European Association of Urology guidelines on urinary and male genital tract infections]. 61
12577160 2003
197
Evolution of the cutaneous immune response to experimental Haemophilus ducreyi infection and its relevance to HIV-1 acquisition. 61
12444138 2002
198
Transmission of human herpesvirus 8 by sexual activity among adults in Lagos, Nigeria. 61
12461423 2002
199
The Haemophilus ducreyi serum resistance antigen DsrA confers attachment to human keratinocytes. 61
12379693 2002
200
Development of a rapid immunodiagnostic test for Haemophilus ducreyi. 61
12354868 2002
201
Erythema nodosum induced by chancroid. 61
12407252 2002
202
Identification and characterization of the N-acetylglucosamine glycosyltransferase gene of Haemophilus ducreyi. 61
12228324 2002
203
The etiology and management of genital ulcers in the Dominican Republic and Peru. 61
12370522 2002
204
Haemophilus ducreyi: clinical features, epidemiology, and prospects for disease control. 61
12361914 2002
205
Pattern of childhood STDs in a major hospital of East Delhi. 61
17656939 2002
206
Spectrum of dermatopathologic lesions associated with HIV/AIDS in India. 61
12785169 2002
207
Validation of syndromic algorithm for the management of genital ulcer diseases in China. 61
12171666 2002
208
Sexually transmitted diseases in the older population in Singapore. 61
12161886 2002
209
AIDS in Papua New Guinea: situation in the Pacific. 61
12186190 2002
210
HIV/STDs in minority women: educational and medical interventions to alter the spread. 61
12099196 2002
211
Improving the National Board of Medical Examiners internal Medicine Subject Exam for use in clerkship evaluation. 61
12133157 2002
212
Haemophilus ducreyi requires the flp gene cluster for microcolony formation in vitro. 61
12010986 2002
213
The cytolethal distending toxin of Haemophilus ducreyi inhibits endothelial cell proliferation. 61
11953409 2002
214
Epidemic Lymphogranuloma venereum during epidemics of crack cocaine use and HIV infection in the Bahamas. 61
11984440 2002
215
Functional studies of the recombinant subunits of a cytolethal distending holotoxin. 61
11952641 2002
216
Immunopathogenesis of Haemophilus ducreyi infection (chancroid). 61
11895928 2002
217
Can behavior change explain increases in the proportion of genital ulcers attributable to herpes in sub-Saharan Africa? A simulation modeling study. 61
11912465 2002
218
A study on the present scenario of STD management in an urban clinic in Kolkata. 61
17656884 2002
219
Changing trends in sexually transmitted diseases in North Eastern India. 61
17656879 2002
220
Men are more susceptible than women to pustule formation in the experimental model of Haemophilus ducreyi infection. 61
11818898 2002
221
Haemophilus ducreyi: clinical disease and pathogenesis. 61
11964905 2002
222
In vitro and in vivo interactions of Haemophilus ducreyi with host phagocytes. 61
11796625 2002
223
Rising incidence of genital herpes over two decades in a sexually transmitted disease clinic in north India. 61
11890299 2002
224
Treatment of sexually transmitted infections with single-dose therapy: a double-edged sword. 61
11929335 2002
225
Chancroid: an update. 61
17656857 2002
226
Development of a heminested polymerase chain reaction assay for the detection of Haemophilus ducreyi in clinical specimens. 61
11779370 2001
227
The legal framework covering the practice of genitourinary medicine in the UK: the Venereal Diseases Regulations. 61
11589807 2001
228
Prevalence of cdtABC genes encoding cytolethal distending toxin among Haemophilus ducreyi and Actinobacillus actinomycetemcomitans strains. 61
11599734 2001
229
Biosynthesis of sialylated lipooligosaccharides in Haemophilus ducreyi is dependent on exogenous sialic acid and not mannosamine. Incorporation studies using N-acylmannosamine analogues, N-glycolylneuraminic acid, and 13C-labeled N-acetylneuraminic acid. 61
11601991 2001
230
A novel heme protein, the Cu,Zn-superoxide dismutase from Haemophilus ducreyi. 61
11369755 2001
231
Haemophilus ducreyi inhibits phagocytosis by U-937 cells, a human macrophage-like cell line. 61
11447144 2001
232
Characterization of Haemophilus ducreyi-specific T-cell lines from lesions of experimentally infected human subjects. 61
11401958 2001
233
Neutrophil degranulation induced by Haemophilus ducreyi. 61
11517937 2001
234
Chancroid. 61
28615569 2001
235
STD update: screening and therapeutic options. 61
11374659 2001
236
Vitamin A and risk of HIV-1 seroconversion among Kenyan men with genital ulcers. 61
11317002 2001
237
The impact of Haemophilus ducreyi cytolethal distending toxin on cells involved in immune response. 61
11273741 2001
238
Eradicating chancroid. 61
11584729 2001
239
Case report. Paraphimosis due to erotic dancing. 61
11169281 2000
240
Cellular internalization of cytolethal distending toxin from Haemophilus ducreyi. 61
11083812 2000
241
An overview of sexually transmitted diseases. Part III. Sexually transmitted diseases in HIV-infected patients. 61
10954653 2000
242
Construction and characterization of Haemophilus ducreyi lipooligosaccharide (LOS) mutants defective in expression of heptosyltransferase III and beta1,4-glucosyltransferase: identification of LOS glycoforms containing lactosamine repeats. 61
10816485 2000
243
Thiamphenicol in the treatment of chancroid. A study of 1,128 cases. 61
10887371 2000
244
Development of a serological test for Haemophilus ducreyi for seroprevalence studies. 61
10747137 2000
245
Diagnostic tests for chancroid. 61
10858718 2000
246
Chancroid in the United Kingdom. 61
10858704 2000
247
Cloning and characterization of the lipooligosaccharide galactosyltransferase II gene of Haemophilus ducreyi. 61
10735874 2000
248
Drug utilisation pattern in sexually transmitted diseases and its economic considerations--a prospective study. 61
11229110 2000
249
Episome profiles and mobilizable beta-lactamase plasmid in Haemophilus ducreyi. 61
11023070 2000
250
Model-based evaluation of single-round mass treatment of sexually transmitted diseases for HIV control in a rural African population. 61
10780720 2000
251
Treatment of sexually transmitted bacterial diseases in pregnant women. 61
10776830 2000
252
Chancroid: from clinical practice to basic science. 61
12240879 2000
253
Update on the experimental human model for chancroid infection. 61
10667906 2000
254
A randomized, double-blind, placebo-controlled trial of single-dose ciprofloxacin versus erythromycin for the treatment of chancroid in Nairobi, Kenya. 61
10558945 1999
255
Expression of sialylated or paragloboside-like lipooligosaccharides are not required for pustule formation by Haemophilus ducreyi in human volunteers. 61
10569746 1999
256
Increasing prevalence of genital herpes in developing countries: implications for heterosexual HIV transmission and STI control programmes. 61
10754939 1999
257
Examination of early interactions between Haemophilus ducreyi and host cells by using cocultured HaCaT keratinocytes and foreskin fibroblasts. 61
10496916 1999
258
Identification of the znuA-encoded periplasmic zinc transport protein of Haemophilus ducreyi. 61
10496878 1999
259
PATTERN OF SEXUALLY TRANSMITTED DISEASES IN THE ARMED FORCES. 61
28790602 1999
260
Relative risks and population attributable fraction of incident HIV associated with symptoms of sexually transmitted diseases and treatable symptomatic sexually transmitted diseases in Rakai District, Uganda. Rakai Project Team. 61
10546865 1999
261
Neutropenia restores virulence to an attenuated Cu,Zn superoxide dismutase-deficient Haemophilus ducreyi strain in the swine model of chancroid. 61
10496915 1999
262
Chancroid, primary syphilis, genital herpes, and lymphogranuloma venereum in Antananarivo, Madagascar. 61
10479178 1999
263
An overview of sexually transmitted diseases. Part I. 61
10495370 1999
264
Drug treatment of common STDs: part I. Herpes, syphilis, urethritis, chlamydia and gonorrhea. 61
10524484 1999
265
Immune cells are required for cutaneous ulceration in a swine model of chancroid. 61
10456960 1999
266
National guideline for the management of chancroid. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). 61
10616383 1999
267
Target cell range of Haemophilus ducreyi hemolysin and its involvement in invasion of human epithelial cells. 61
10417132 1999
268
Characterization of a Haemophilus ducreyi mutant deficient in expression of cytolethal distending toxin. 61
10417154 1999
269
Prevalence of, antibody response to, and immunity induced by Haemophilus ducreyi hemolysin. 61
10377108 1999
270
The dnaK/dnaJ operon of Haemophilus ducreyi contains a unique combination of regulatory elements. 61
10375627 1999
271
Molecular characterization of Haemophilus ducreyi strains from Jackson, Mississippi, and New Orleans, Louisiana. 61
10228064 1999
272
Sexually transmitted diseases: testing and treating. 61
10370707 1999
273
Genital ulcers: etiology, clinical diagnosis, and associated human immunodeficiency virus infection in Kingston, Jamaica. 61
10452639 1999
274
Hiv infection in patients of sexually transmitted disease. 61
20921634 1999
275
Investigation of the kinetic mechanism of cytidine 5'-monophosphate N-acetylneuraminic acid synthetase from Haemophilus ducreyi with new insights on rate-limiting steps from product inhibition analysis. 61
10320348 1999
276
Haemophilus ducreyi produces a novel sialyltransferase. Identification of the sialyltransferase gene and construction of mutants deficient in the production of the sialic acid-containing glycoform of the lipooligosaccharide. 61
9933604 1999
277
The use of experimental animal and human models in the study of chancroid pathogenesis. 61
10215110 1999
278
[Chronic genital ulcerations and HIV infection: 29 cases]. 61
10701208 1999
279
Haemophilus ducreyi Detection by PCR. 61
21390728 1999
280
The cytolethal distending toxin from the chancroid bacterium Haemophilus ducreyi induces cell-cycle arrest in the G2 phase. 61
9884340 1999
281
[Chancroid]. 61
10337725 1999
282
Treatment of chancroid, 1997. 61
10028106 1999
283
The immune response to Haemophilus ducreyi resembles a delayed-type hypersensitivity reaction throughout experimental infection of human subjects. 61
9815221 1998
284
Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities. The Genital Ulcer Disease Surveillance Group. 61
9815237 1998
285
Haemophilus ducreyi secretes a filamentous hemagglutinin-like protein. 61
9811662 1998
286
Genital ulcers in a primary health clinic in Rwanda: impact of HIV infection on diagnosis and ulcer healing (1986-1992). 61
9863586 1998
287
Comparison of culture media for the laboratory diagnosis of chancroid. 61
9822303 1998
288
An investigation of genital ulcers in Jackson, Mississippi, with use of a multiplex polymerase chain reaction assay: high prevalence of chancroid and human immunodeficiency virus infection. 61
9806035 1998
289
Haemophilus ducreyi is susceptible to protegrin. 61
9756778 1998
290
Cutaneous manifestations of sexually transmitted diseases. 61
9769794 1998
291
Clinical and in situ cellular responses to Haemophilus ducreyi in the presence or absence of HIV infection. 61
9764937 1998
292
Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi. 61
9712686 1998
293
Rapid identification and speciation of Haemophilus bacteria by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. 61
9745723 1998
294
Molecular methods for the diagnosis of genital ulcer disease in a sexually transmitted disease clinic population in northern Thailand: predominance of herpes simplex virus infection. 61
9652447 1998
295
Evaluation of an isogenic hemolysin-deficient mutant in the human model of Haemophilus ducreyi infection. 61
9652440 1998
296
Facile construction of mutations in Haemophilus ducreyi using lacZ as a counter-selectable marker. 61
9682476 1998
297
A comparative study of therapeutic response of patients with clinical chancroid to ciprofloxacin, erythromycin, and cotrimoxazole. 61
9662762 1998
298
HIV-1 DNA shedding in genital ulcers and its associated risk factors in Pune, India. 61
9665506 1998
299
Drugs for STD management in developing countries: choice, procurement, cost, and financing. 61
10023369 1998
300
Comparison of clinically directed, disease specific, and syndromic protocols for the management of genital ulcer disease in Lesotho. 61
10023349 1998
301
Haemophilus ducreyi infection causes basal keratinocyte cytotoxicity and elicits a unique cytokine induction pattern in an In vitro human skin model. 61
9596767 1998
302
Prevention of experimental Haemophilus ducreyi infection: a randomized, controlled clinical trial. 61
9607840 1998
303
A serosurvey of Haemophilus ducreyi, syphilis, and herpes simplex virus type 2 and their association with human immunodeficiency virus among female sex workers in Lagos, Nigeria. 61
9587174 1998
304
The rrs (16S)-rrl (23S) ribosomal intergenic spacer region as a target for the detection of Haemophilus ducreyi by a heminested-PCR assay. 61
9579075 1998
305
Oral sex and transmission of non-viral STIs. 61
9634339 1998
306
DETECTION OF HIV INFECTION IN MEN SUFFERING FROM SEXUALLY TRANSMITTED DISEASES IN NORTH EAST REGION. 61
28775435 1998
307
High occurrence of HBV among STD clinic attenders in Bombay, India. 61
9598752 1998
308
Polymerase chain reaction detection of Haemophilus ducreyi DNA. 61
9634308 1998
309
The sodA gene of Haemophilus ducreyi encodes a hydrogen peroxide-inhibitable superoxide dismutase. 61
9511768 1998
310
Periplasmic copper-zinc superoxide dismutase protects Haemophilus ducreyi from exogenous superoxide. 61
9484894 1998
311
Chancroid. 61
21390754 1998
312
STD vaccines--an overview. 61
9534740 1997
313
A comparison of prevalence rates of genital ulcers among persons attending a sexually transmitted disease clinic in Jamaica. 61
9361493 1997
314
Immunohistochemical investigations of genital ulcers caused by Haemophilus ducreyi. 61
9292349 1997
315
Sero surveillance of HIV infection in high risk groups and in suspected AIDS cases in a New Delhi hospital. 61
9465534 1997
316
High HIV prevalence, low condom use and gender differences in sexual behaviour among patients with STD-related complaints at a Nairobi primary health care clinic. 61
9259499 1997
317
Purification and identification of Haemophilus ducreyi cytotoxin by use of a neutralizing monoclonal antibody. 61
9234821 1997
318
Characterization of a transposon Tn916-generated mutant of Haemophilus ducreyi 35000 defective in lipooligosaccharide biosynthesis. 61
9260947 1997
319
The clinical diagnosis of genital ulcer disease in men. 61
9332527 1997
320
Routinely reported sexually transmitted diseases presage the evolution of the AIDS epidemic. 61
9209863 1997
321
Alterations in levels of DnaK and GroEL result in diminished survival and adherence of stressed Haemophilus ducreyi. 61
9169782 1997
322
Survey of patients with sexually transmitted diseases seen by private physicians in Jamaica. 61
9260533 1997
323
Comparison of enzyme immunoassays for antibodies to Haemophilus ducreyi in a community outbreak of chancroid in the United States. 61
9180178 1997
324
Prospective analysis of genital ulcer disease in Brooklyn, New York. 61
9142798 1997
325
A diffusible cytotoxin of Haemophilus ducreyi. 61
9108104 1997
326
Distribution, cloning, characterisation and mutagenesis of sodC, the gene encoding copper/zinc superoxide dismutase, a potential determinant of virulence, in Haemophilus ducreyi. 61
9143881 1997
327
Comparison of clinical diagnosis and standard laboratory and molecular methods for the diagnosis of genital ulcer disease in Lesotho: association with human immunodeficiency virus infection. 61
9041329 1997
328
Iron and virulence of Haemophilus ducreyi in a primate model. 61
9111750 1997
329
[Chancroid in Algeria: the status of this sexually transmitted disease in 1995]. 61
9289257 1997
330
HIV-1 infection among female commercial sex workers in rural Thailand. 61
9110080 1997
331
Attachment of Haemophilus ducreyi to human foreskin fibroblasts involves LOS and fibronectin. 61
9032761 1997
332
Health-seeking behaviour of STD patients in an urban area of southwest Nigeria: an exploratory study. 61
10169652 1997
333
Characterization of a novel lipoprotein expressed by Haemophilus ducreyi. 61
8945545 1996
334
A morphological study of penile chancroid lesions in human immunodeficiency virus (HIV)-positive and -negative African men with a hypothesis concerning the role of chancroid in HIV transmission. 61
8892592 1996
335
Ribosomal DNA typing of Haemophilus ducreyi strains: proposal for a novel typing scheme. 61
8880534 1996
336
[Epidemiology of sexually transmitted diseases, with the exception of AIDS]. 61
8978200 1996
337
Mucocutaneous disorders in Hiv positive patients. 61
20948090 1996
338
Gammabenzene hexachloride-induced convulsions in an HIV positive individual. 61
20948097 1996
339
An immunohistochemical analysis of naturally occurring chancroid. 61
8699082 1996
340
Update on chancroid: an important cause of genital ulcer disease. 61
11361592 1996
341
Laboratory diagnosis of sexually transmitted diseases in facilities within the United States. Results of a national survey. 61
8836028 1996
342
Amebiasis of the penis. 61
8693642 1996
343
Sexually transmitted diseases: a survey of case management in Malawi. 61
8876358 1996
344
Human immunodeficiency virus transmission and the role of other sexually transmitted diseases. Measures of association and study design. 61
8836026 1996
345
Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability. 61
8736621 1996
346
The conserved 18,000-molecular-weight outer membrane protein of Haemophilus ducreyi has homology to PAL. 61
8675292 1996
347
Sexually transmitted diseases in South Africa. 61
8707316 1996
348
Haemophilus ducreyi hemolysin acts as a contact cytotoxin and damages human foreskin fibroblasts in cell culture. 61
8675349 1996
349
Presumptive specific clinical diagnosis of genital ulcer disease (GUD) in a primary health care setting in Nairobi. 61
8799783 1996
350
Evaluation of humoral and cell-mediated inducible immunity to Haemophilus ducreyi in an animal model of chancroid. 61
8613391 1996
351
Trends in the acquisition of sexually transmitted diseases among HIV-positive patients at STD clinics, Miami 1988-1992. 61
8724514 1996
352
Epidemiologic risk factors for incident sexually transmitted diseases in young Thai men. 61
8724509 1996
353
The place of quinolones in everyday clinical practice. 61
9091272 1996
354
A prospective clinical and bacteriologic study of inguinal buboes in Thai men. 61
8838178 1996
355
Chancroid and TMP-SMX. 61
11361672 1996
356
Herpes, Syphilis, and Other Ulcerogenital Conditions. 61
10359960 1996
357
Trends in HIV seroprevalence in men who have sex with men: New York City Department of Health sexually transmitted disease clinics, 1988-1993. 61
8838707 1996
358
[Venereal vegetations of the urogenital tract and their urological complications. Apropos of 257 cases]. 61
9833026 1996
359
Treatment of chancroid with azithromycin. 61
8652728 1996
360
Chancroid. 61
8743249 1996
361
Chancroid. 61
8743258 1996
362
Std trends in chengalpattu hospital. 61
20947955 1996
363
Enhanced recovery of Haemophilus ducreyi from clinical specimens by incubation at 33 versus 35 degrees C. 61
8586712 1995
364
Characterization of the hemolytic activity of Haemophilus ducreyi. 61
7591078 1995
365
In vitro stimulation of peripheral blood mononuclear cells (PBMC) from HIV- and HIV+ chancroid patients by Haemophilus ducreyi antigens. 61
7586673 1995
366
Laboratory diagnosis of chancroid using species-specific primers from Haemophilus ducreyi groEL and the polymerase chain reaction. 61
8849652 1995
367
Chancroid detected by polymerase chain reaction--Jackson, Mississippi, 1994-1995. 61
8578414 1995
368
Low dose erythromycin regimen for the treatment of chancroid. 61
8904044 1995
369
Monoclonal antibodies against Haemophilus ducreyi lipooligosaccharide and their diagnostic usefulness. 61
8605903 1995
370
Localisation and immunological properties of a 24-kDa surface protein of Haemophilus ducreyi. 61
7650727 1995
371
Swine model of Haemophilus ducreyi infection. 61
7622236 1995
372
Asymptomatic carriage of Haemophilus ducreyi confirmed by the polymerase chain reaction. 61
7590712 1995
373
Chancroid detected by polymerase chain reaction--Jackson, Mississippi, 1994-1995. 61
7616954 1995
374
Comparison of azithromycin and ceftriaxone for the treatment of chancroid. 61
8562752 1995
375
Chancroid epidemiology in New Orleans men. 61
7622888 1995
376
Chancroid and Haemophilus ducreyi: an update. 61
7553570 1995
377
Incision and drainage versus aspiration of fluctuant buboes in the emergency department during an epidemic of chancroid. 61
7482103 1995
378
Specificity of the immune response to Haemophilus ducreyi. 61
8559038 1995
379
Antimicrobial therapy of non-viral sexually transmitted diseases--an update. 61
8849192 1995
380
Sexually transmitted disease services in Madras: could their role in AIDS prevention be strengthened? 61
8690498 1995
381
Sexually transmitted diseases in Australia: a decade of change. Epidemiology and surveillance. 61
8849191 1995
382
Epidemiology of sexually transmitted diseases in Singapore, 1977 to 1993. 61
8849175 1995
383
Genital ulcer disease in patients attending a public sexually transmitted disease clinic in Singapore: an epidemiologic study. 61
8849178 1995
384
Use of tissue culture and animal models to identify virulence-associated traits of Haemophilus ducreyi. 61
7729882 1995
385
Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections. 61
7601015 1995
386
Clinical profile of sexual transmitted diseases in cuttack. 61
20952928 1995
387
Combinations of sulphonamides with diaminopyrimidines: how, when and why? 61
7666120 1995
388
Failure of treatment for chancroid in Rwanda is not related to human immunodeficiency virus infection: in vitro resistance of Haemophilus ducreyi to trimethoprim-sulfamethoxazole. 61
7795096 1995
389
Recommendations for treatment of chancroid, 1993. 61
7795108 1995
390
Single dose trimethoprim-sulphamethoxazole for treatment of chancroid. 61
7744411 1995
391
Alterations in sample preparation increase sensitivity of PCR assay for diagnosis of chancroid. 61
7790433 1995
392
Simplified PCR for detection of Haemophilus ducreyi and diagnosis of chancroid. 61
7540625 1995
393
Haemophilus ducreyi: pathogenesis and protective immunity. 61
7773593 1995
394
HIV and STDs: how are they linked? 61
12288717 1995
395
Ceftriaxone in the management of chancroid. 61
20952915 1995
396
Sexually transmitted diseases and human immunodeficiency virus control in Malawi: a field study of genital ulcer disease. 61
7844388 1995
397
Increasing HIV-1 seroprevalence associated with genital ulcer disease, New York City, 1990-1992. 61
7718189 1995
398
Simple algorithms for the management of genital ulcers: evaluation in a primary health care centre in Kigali, Rwanda. 61
8907769 1995
399
Quinolones in sexually transmitted diseases. Global experience. 61
8549279 1995
400
Therapeutic algorithms for the management of sexually transmitted diseases at the peripheral level in Côte d'Ivoire: assessment of efficacy and cost. 61
7614662 1995
401
The use of fluoroquinolones in sexually transmitted diseases in Southeast Asia. 61
8549280 1995
402
Sexually transmitted diseases in children. 61
8617530 1995
403
Chancroid: new developments in an old disease. 61
7546365 1995
404
The 1993 sexually transmitted disease treatment guidelines. 61
7848821 1994
405
Vaccines for classic sexually transmitted diseases. 61
7890936 1994
406
Pattern of sexually transmitted diseases in a Malagasy population. 61
7871444 1994
407
Structure of the major oligosaccharide from the lipooligosaccharide of Haemophilus ducreyi strain 35000 and evidence for additional glycoforms. 61
7947712 1994
408
Genital ulcer disease. 61
7805305 1994
409
Characterization of the cytopathic effect of Haemophilus ducreyi. 61
7817258 1994
410
A socioeconomic, clinical and serological study in an African city of prostitutes and women still married to their first husband. 61
7939848 1994
411
Clear broth and plate media for culture of Haemophilus ducreyi. 61
7989562 1994
412
Identification of a hemolytic activity elaborated by Haemophilus ducreyi. 61
8005696 1994
413
Single dose azithromycin for the treatment of chancroid: a randomized comparison with erythromycin. 61
7974076 1994
414
Emergence of Haemophilus ducreyi resistance to trimethoprim-sulfamethoxazole in Rwanda. 61
7979300 1994
415
Circumcision in the control of HIV? 61
12318892 1994
416
Use of pyocin to select a Haemophilus ducreyi variant defective in lipooligosaccharide biosynthesis. 61
8188362 1994
417
Sexually transmitted diseases in HIV-infected persons. 61
8089470 1994
418
A primate model for chancroid. 61
8195605 1994
419
Experimental human infection with Haemophilus ducreyi. 61
8169411 1994
420
Recent changes in the epidemiology of genital ulcer disease in the United States. The crack cocaine connection. 61
8042123 1994
421
Sexually transmitted diseases in the tropics. 61
8133821 1994
422
Gross and microscopic features in chancroid: a study in 200 new culture-proven cases in San Salvador. 61
9071423 1994
423
Development of sexually transmitted diseases treatment guidelines, 1993. New methods, recommendations, and research priorities. STD Treatment Guidelines Project Team and Consultants. 61
8042129 1994
424
Vaccines for bacterial sexually transmitted infections: a realistic goal? 61
8146139 1994
425
Haemophilus ducreyi adheres to human keratinocytes. 61
8090082 1994
426
Limitations of and indications for the use of co-trimoxazole. 61
8071675 1994
427
Genital ulcer disease: accuracy of clinical diagnosis and strategies to improve control in Durban, South Africa. 61
8300105 1994
428
Mucocutaneous manifestations of chancroid, lymphogranuloma venereum and granuloma inguinale. 61
8304262 1994
429
[Chancroid in Yaounde. Apropos of 42 cases]. 61
7979020 1994
430
Induction of protective immunity to Haemophilus ducreyi in the temperature-dependent rabbit model of experimental chancroid. 61
8254191 1994
431
Laboratory techniques used in the diagnosis of chancroid, granuloma inguinale, and lymphogranuloma venereum. 61
8143374 1994
432
Enzyme immunoassays (EIAs) for the detection of anti-Haemophilus ducreyi serum IgA, IgG, and IgM antibodies. 61
8140487 1994
433
[Importance of culture media choice in the isolation of Haemophilus ducreyi. Experience in Senegal]. 61
8003900 1994
434
Development of a polymerase chain reaction assay for the detection of Haemophilus ducreyi. 61
8140483 1994
435
Treatment of bacterial sexually transmitted diseases. 61
8080504 1993
436
HIV-1 seroconversion in patients with and without genital ulcer disease. A prospective study. 61
8239249 1993
437
Osteomyelitis presenting as genital sore: a case report. 61
8282301 1993
438
[Soft chancroid: 4 clinical cases]. 61
8117887 1993
439
Human immunodeficiency virus seropositivity in adolescents with syphilis. 61
8414857 1993
440
Haemophilus ducreyi. 61
8305570 1993
441
HIV and other sexually transmitted diseases at a rural hospital in Zimbabwe. 61
8244351 1993
442
1993 sexually transmitted diseases treatment guidelines. Centers for Disease Control and Prevention. 61
8145706 1993
443
Sexually-transmitted diseases, AIDS and traditional healers in Mozambique. 61
8114622 1993
444
Soap and water prophylaxis for limiting genital ulcer disease and HIV-1 infection in men in sub-Saharan Africa. 61
7721293 1993
445
Antibodies directed against Haemophilus ducreyi heat shock proteins. 61
8255206 1993
446
Antigen detection and immunological typing of Haemophilus ducreyi with a specific rabbit polyclonal serum. 61
8349759 1993
447
In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid. 61
8363390 1993
448
[Sexually transmissible diseases following travel in tropical countries]. 61
8327873 1993
449
Evidence of Haemophilus ducreyi adherence to and cytotoxin destruction of human epithelial cells. 61
8412616 1993
450
Haemophilus ducreyi adheres to but does not invade cultured human foreskin cells. 61
8478062 1993
451
Humoral immune response of humans to lipooligosaccharide and outer membrane proteins of Haemophilus ducreyi. 61
8486955 1993
452
The suppressive effect of serum samples from patients with chancroid on human mononuclear cells correlates with the clinical picture and is interleukin-2-dependent. 61
8324045 1993
453
Multistrain outbreak of chancroid in San Francisco, 1989-1991. 61
8098052 1993
454
[Prevention of sexually transmitted diseases or control of prostitutes and patients with venereal diseases? An exemplary, epicritical study in Bremen]. 61
8507994 1993
455
Non-radioactive ribotyping of Haemophilus ducreyi using a digoxigenin labelled cDNA probe. 61
8386096 1993
456
Fleroxacin in the treatment of chancroid: an open study in men seropositive or seronegative for the human immunodeficiency virus type 1. 61
8452188 1993
457
Development of the polymerase chain reaction for diagnosis of chancroid. 61
8458959 1993
458
Ceftriaxone no longer predictably cures chancroid in Kenya. 61
8421184 1993
459
Human immunodeficiency virus-1 infection among patients with sexually transmitted diseases in Bombay. 61
8453353 1993
460
Quinolones in sexually transmitted diseases. 61
7689444 1993
461
In vitro susceptibility of Haemophilus ducreyi to several antibiotics. 61
8361391 1993
462
Transport media for Haemophilus ducreyi. 61
8430358 1993
463
Identification of highly conserved and species-specific polypeptides of Haemophilus ducreyi. 61
1281234 1992
464
Use of an adsorption enzyme immunoassay to evaluate the Haemophilus ducreyi specific and cross-reactive humoral immune response of humans. 61
1492255 1992
465
Evaluation of new anti-infective drugs for the treatment of chancroid. Infectious Diseases Society of America and the Food and Drug Administration. 61
1477217 1992
466
Sexually transmitted diseases and travelers. 61
1405828 1992
467
A simple medium for the primary isolation of Haemophilus ducreyi. 61
1486890 1992
468
Molecular analysis of the Haemophilus ducreyi groE heat shock operon. 61
1356926 1992
469
The role of Haemophilus ducreyi bacteria, cytotoxin, endotoxin and antibodies in animal models for study of chancroid. 61
1291843 1992
470
Pathophysiological concept of Haemophilus ducreyi infection (chancroid) 61
1391058 1992
471
Treatment of chancroid with a single dose of spectinomycin. 61
1411847 1992
472
Standardization of an enzyme immunoassay for human antibody to Haemophilus ducreyi. 61
1500508 1992
473
Use of electroporation to construct isogenic mutants of Haemophilus ducreyi. 61
1644771 1992
474
Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States. 61
1416845 1992
475
Partial characterization of the major lipooligosaccharide from a strain of Haemophilus ducreyi, the causative agent of chancroid, a genital ulcer disease. 61
1618845 1992
476
Chancroid in the United States, 1981-1990: evidence for underreporting of cases. 61
1635549 1992
477
A randomized, double-blind study of the efficacy of fleroxacin versus trimethoprim-sulfamethoxazole in men with culture-proven chancroid. 61
1569347 1992
478
Association between HIV-2 infection and genital ulcer diseases among male sexually transmitted disease patients in The Gambia. 61
1616655 1992
479
Laboratory techniques in the investigation of chancroid, lymphogranuloma venereum and donovanosis. 61
1582657 1992
480
The situation in Africa. 61
1633656 1992
481
Haemophilus ducreyi, a cytotoxin-producing bacterium. 61
1541531 1992
482
Characterization of an 18,000-molecular-weight outer membrane protein of Haemophilus ducreyi that contains a conserved surface-exposed epitope. 61
1370430 1992
483
Update on bacterial sexually transmitted disease. 61
1736477 1992
484
Mechanisms of skin adherence, penetration and tissue necrosis production by Haemophilus ducreyi, the causative agent of chancroid. 61
1636361 1992
485
[The reappearance of chancroid in Algeria]. 61
1446174 1992
486
Cultural diagnosis of chancroid. 61
1845282 1991
487
Mouse subcutaneous chamber model for in vivo growth of Haemophilus ducreyi. 61
1816492 1991
488
A microbiological study of genital ulcers in Kuala Lumpur. 61
1839925 1991
489
Molecular characterization of Haemophilus ducreyi by ribosomal DNA fingerprinting. 61
1663518 1991
490
Chancroid: a review for the family practitioner. 61
1956085 1991
491
Sexually transmitted diseases: bacterial infections. Committee on Sexually Transmitted Diseases of the American Academy of Dermatology. 61
1918468 1991
492
Genital ulcer disease in women in Durban, South Africa. 61
1655626 1991
493
Genital ulcer disease in men in Durban, South Africa. 61
1655627 1991
494
Role of lipooligosaccharides in experimental dermal lesions caused by Haemophilus ducreyi. 61
1855979 1991
495
A temperature-dependent rabbit model for production of dermal lesions by Haemophilus ducreyi. 61
1856485 1991
496
Condom use prevents genital ulcers in women working as prostitutes. Influence of human immunodeficiency virus infection. 61
1948518 1991
497
Recent developments in STDs: I. Bacterial diseases. 61
2071682 1991
498
Isolation of anaerobes from clinical chancroid associated with fluctuant bubo in men. 61
1959953 1991
499
[Epidemiology of sexually transmissible diseases in developing countries in the era of AIDS]. 61
1929603 1991
500
Chancroid in Dallas: new lessons from an old disease. 61
1882362 1991
501
Crack, sex, and STD. 61
1862466 1991
502
Isolation of anaerobes from bubo associated with chancroid. 61
1680792 1991
503
The development of specific rRNA-derived oligonucleotide probes for Haemophilus ducreyi, the causative agent of chancroid. 61
1707945 1991
504
Intravenous single-dose ceftriaxone treatment of chancroid. 61
1743374 1991
505
Chancroid: results from an outbreak in Houston, Texas. 61
2251526 1990
506
Sexually transmitted diseases in leprosy patients in north and northeastern India. A futile search for human immunodeficiency virus antibody. 61
2280116 1990
507
Characterization of pili expressed by Haemophilus ducreyi. 61
1982953 1990
508
Approach to the patient with genital ulcer disease. 61
2246953 1990
509
Chancroid and the role of genital ulcer disease in the spread of human retroviruses. 61
2246947 1990
510
Accuracy of clinical diagnosis of genital ulcer disease. 61
2175951 1990
511
Office and Laboratory Testing for STDs: Present and Future. 61
10350732 1990
512
A comparative study of spectinomycin and erythromycin in the treatment of chancroid. 61
2146242 1990
513
The prevalence of symptomatic sexually transmitted diseases and human immunodeficiency virus infection in outpatients in Lilongwe, Malawi. 61
2391110 1990
514
Soluble interleukin-2 receptors in serum and urine of patients with chancroid and their response to therapy. 61
2088539 1990
515
'Imported' sexually transmitted diseases. 61
21233914 1990
516
Vulvar ulcer of unknown etiology in a human immunodeficiency virus-infected woman: response to treatment with zidovudine. 61
2375334 1990
517
HIV seropositivity among patients with sexually transmitted diseases in Vellore. 61
2228049 1990
518
Treatment of chancroid, 1989. 61
2201074 1990
519
Treatment of chancroid. 61
2201249 1990
520
The epidemiology of sexually transmitted diseases in Southeast Asia and the western Pacific. 61
2117964 1990
521
The epidemiology of sexually transmitted diseases in Africa and Latin America. 61
2202406 1990
522
Diagnosis and management of acute genital ulcers in sexually active patients. 61
2202412 1990
523
Drug resistance of Haemophilus ducreyi. 61
2237585 1990
524
Rapid control of a chancroid outbreak: implications for Canada. 61
2337844 1990
525
Treatment of chancroid with spectinomycin or co-trimoxazole. 61
2165860 1990
526
Atypical presentation of chancroid in a patient infected with the human immunodeficiency virus. 61
2368772 1990
527
Sulphaphenazole, streptomycin and sulphaphenazole combination, trimethoprim, and erythromycin in the treatment of chancroid. 61
2187791 1990
528
Recent advances in sexually transmitted diseases: reflections on the Center for Disease Control's new sexually transmitted diseases treatment guidelines from the viewpoint of a private practitioner: human immunodeficiency virus (HIV), genital ulcers, chancroid, and syphilis. 61
2158416 1990
529
Characterization of skin lesions in mice following intradermal inoculation of Haemophilus ducreyi. 61
2331407 1990
530
Chancroid. 61
2181505 1990
531
Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use. 61
2184003 1990
532
Use of the RapID-ANA system and sodium polyanetholesulfonate disk susceptibility testing in identifying Haemophilus ducreyi. 61
2153697 1990
533
Human immunodeficiency virus, genital ulcers and the male foreskin: synergism in HIV-1 transmission. 61
2263893 1990
534
Epidemiology of sexually transmitted diseases: the global picture. 61
2289300 1990
535
Diagnosis and management of sexually transmitted genital lesions. 61
2405300 1990
536
Rapid detection of Haemophilus ducreyi in clinical and experimental infections using monoclonal antibody: a preliminary evaluation. 61
2693334 1989
537
Quinolone antibacterial agents for the treatment of genitourinary tract infections. 61
2695332 1989
538
Biology of Haemophilus ducreyi. 61
2687678 1989
539
Clinical efficacy of antimicrobial therapy in Haemophilus ducreyi infections. 61
2679402 1989
540
Causes and treatment of sexually acquired genital ulceration in southern Africa. 61
2799580 1989
541
[Sexually-transmissible anorectal diseases]. 61
2682913 1989
542
Lymphogranuloma venereum: 27 cases in Paris. 61
2677162 1989
543
Treating chancroid: summary of studies in South Africa. 61
2583721 1989
544
Chancroid. A newly important sexually transmitted disease. 61
2802648 1989
545
Lymphogranuloma venereum, chancroid, and granuloma inguinale. 61
2687744 1989
546
Chancroid and granuloma inguinale. 61
2676322 1989
547
Recent developments in sexually transmitted diseases: chancroid--epidemiology, diagnosis, and treatment. 61
2667898 1989
548
[The etiopathogenesis of ulcus molle: current status of knowledge--approaches to future research]. 61
2668228 1989
549
[Diagnosis and therapy of ulcus molle today. Case report and review of the literature]. 61
2668230 1989
550
The etiology of genital ulceration in Rwanda. 61
2510325 1989
551
Results of treatment with quinolones of sexually transmitted diseases in the Far East: a brief summary. 61
2672256 1989
552
Incidence of chancroid in Vienna from 1980 to 1988. 61
2788626 1989
553
[Morphologic variants of genital ulcer caused by Haemophilus ducreyi]. 61
2788154 1989
554
Production of monoclonal antibodies specific for Haemophilus ducreyi: a screening method to discriminate specific and cross-reacting antibodies. 61
2787274 1989
555
Evaluation of fleroxacin (RO 23-6240) as single-oral-dose therapy of culture-proven chancroid in Nairobi, Kenya. 61
2502065 1989
556
Chancroid and Haemophilus ducreyi. 61
2650859 1989
557
Persistent genital ulceration. Chancroid. 61
2467625 1989
558
Imported pedal chancroid: case report. 61
2753511 1989
559
Comparison of Sheffield media with standard media for the isolation of Haemophilus ducreyi. 61
2662437 1989
560
Role of ceftriaxone in sexually transmitted diseases. 61
2649963 1989
561
Quinolones in the treatment of sexually transmitted diseases. 61
2646055 1989
562
A study of morbidity pattern among prostitutes attending a municipal clinic in Pune. 61
2789264 1989
563
Chancroid and HIV. 61
2493913 1989
564
Chancroid. 61
2495094 1989
565
Chancroid. 61
2493294 1989
566
Treating chancroid: summary of studies in southern Africa. 61
2629710 1989
567
Winnipeg suffered second chancroid outbreak, team reports. 61
2909280 1989
568
International travel and sexually transmitted diseases. 61
2678762 1989
569
Antibiotic susceptibilities and plasmid profiles of Haemophilus ducreyi isolates from southern Africa. 61
3264554 1988
570
In vitro activity of azithromycin and erythromycin against organisms associated with bacterial vaginosis and chancroid. 61
3141171 1988
571
Chancroid: clinical variants and other findings from an epidemic in Dallas County, 1986-1987. 61
3049692 1988
572
The treatment of gonorrhea, syphilis, chancroid, lymphogranuloma venereum, and granuloma inguinale. 61
3042224 1988
573
Treating chancroid with enoxacin. 61
3044978 1988
574
Use of an enzyme immunoassay to detect serum IgG antibodies to Haemophilus ducreyi. 61
3283255 1988
575
Chancroid in El Salvador. Increasing incidence, clinical features, and therapeutics. 61
3391712 1988
576
Evaluation of 500- and 1,000-mg doses of ciprofloxacin for the treatment of chancroid. 61
3293526 1988
577
Pattern of Sexually Transmitted Diseases in and Around Udaipur. 61
28134154 1988
578
Chancroid in Liverpool. 61
3346032 1988
579
Genital ulceration as a risk factor for human immunodeficiency virus infection. 61
3128996 1988
580
Laboratory diagnosis of chancroid. 61
3266100 1988
581
Chancroid outbreak--Winnipeg, Manitoba. 61
3233672 1988
582
[The campaign against sexually transmissible diseases and endemic treponematoses]. 61
2459857 1988
583
Urethral infection with Haemophilus ducreyi in men. 61
3258676 1988
584
Clinical and microbiological efficacy of a single dose of norfloxacin in the treatment of chancroid. 61
3074466 1988
585
Efficacy and safety of a single dose therapy of a 500 mg ciprofloxacin tablet in chancroid patients. 61
3286513 1988
586
[Genital ulcers in French Guyana. Apropos of 231 cases screened in 2 years]. 61
3367760 1988
587
Chancroid in the United States. Reestablishment of an old disease. 61
2824868 1987
588
Aetiology of genital ulceration in the Gambia. 61
3679217 1987
589
Chancroid--a review. 61
3328556 1987
590
[Diagnosis and therapy of ulcus molle]. 61
3318086 1987
591
Pattern of Sexually Transmitted Diseases in Chandigarh. 61
28145373 1987
592
Histological aspects of sexually transmitted genital lesions. 61
3623440 1987
593
Genital ulcers: their diagnosis and management. 61
21263799 1987
594
In vitro activity of ceftriaxone, cefetamet (Ro 15-8074), ceftetrame (Ro 19-5247; T-2588), and fleroxacin (Ro 23-6240; AM-833) versus Neisseria gonorrhoeae and Haemophilus ducreyi. 61
2959199 1987
595
Ceftriaxone in the treatment of chancroid. 61
3509497 1987
596
Retrospective seroepidemiology of AIDS virus infection in Nairobi populations. 61
3471817 1987
597
[Clinical observations on urethritis over the last eight years in Gifu City Hospital]. 61
2959123 1987
598
Problems in the treatment of bacterial sexually transmitted diseases. 61
3555053 1987
599
Treatment of chancroid with ciprofloxacin. A prospective, randomized clinical trial. 61
3555055 1987
600
A comparison of single-dose spectinomycin with five days of trimethoprim-sulfamethoxazole for the treatment of chancroid. 61
2956702 1987
601
Clinical and microbiological evaluation of 46 episodes of genital ulceration. 61
3034762 1987
602
Haemophilus ducreyi infection in south Florida: a rare disease on the rise? 61
3492766 1987
603
Role of cephalosporins in gonorrhoea and other sexually transmitted diseases. 61
3319500 1987
604
Etiology of nonvesicular genital ulcers in Winnipeg. 61
3494322 1987
605
Single-dose ceftriaxone for chancroid. 61
3566241 1987
606
The diagnosis and treatment of chancroid. 61
3782534 1986
607
Isolation and identification of Haemophilus ducreyi in a clinical laboratory. 61
3489097 1986
608
Problems in the treatment of bacterial sexually transmitted diseases. 61
3532369 1986
609
Clinical evaluation of rosoxacin for the treatment of chancroid. 61
3489439 1986
610
Advances in the diagnosis and management of chancroid. 61
3532370 1986
611
Single-dose therapy with trimethoprim-sulfametrole for chancroid in females. 61
3764627 1986
612
Three day oral course of Augmentin to treat chancroid. 61
3733082 1986
613
Laboratory diagnosis of chancroid in Nairobi, Kenya. 61
3533507 1986
614
Use of dot-immunobinding and immunofluorescence assays to investigate clinically suspected cases of chancroid. 61
3517183 1986
615
The treatment of chancroid. 61
3512872 1986
616
Leads from the MMWR. Chancroid--Massachusetts. 61
3485202 1986
617
Laboratory diagnosis of Haemophilus ducreyi: sensitivity of culture media. 61
3485507 1986
618
Chancroid. Recent advances in treatment and control. 61
3485081 1986
619
[Case report of an atypical course of chancroid]. 61
3556695 1986
620
Pattern of sexually transmitted disease in Madurai, India. 61
3841335 1985
621
Comparative study of ceftriaxone and trimethoprim-sulfamethoxazole for the treatment of chancroid in Thailand. 61
3876396 1985
622
Sexually transmitted diseases. 61
3902459 1985
623
Chancroid--Massachusetts. 61
3932837 1985
624
Cotrimoxazole Resistant Chancroid. 61
28164910 1985
625
Clinical and microbiologic studies of genital ulcers in Kenyan women. 61
3878601 1985
626
Trimethoprim sulphamoxole in the treatment of chancroid. Comparison of two single dose treatment regimens with a five day regimen. 61
3876325 1985
627
[Digestive localizations of sexually transmitted diseases in male homosexuals]. 61
3160035 1985
628
Chancroid and Haemophilus ducreyi. 61
3872617 1985
629
An outbreak of chancroid in Orange County, California: descriptive epidemiology and disease-control measures. 61
2985711 1985
630
Haemophilus ducreyi. 61
3888902 1985
631
Short-course treatment of chancroid with co-trimoxazole (Septrin) 61
3890302 1985
632
Antimicrobial susceptibility and characterization of outer membrane proteins of Haemophilus ducreyi isolated in Thailand. 61
3872313 1985
633
Chancroid or chancroidal ulcers. 61
3979640 1985
634
Treatment of chancroid with enoxacin. 61
2416179 1985
635
Beta-lactams in sexually transmitted diseases: rationale for selection and dosing regimens. 61
6098477 1984
636
Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination. 61
6391783 1984
637
Cefotaxime treatment of Haemophilus ducreyi infection in Kenya. 61
6098034 1984
638
Thiamphenicol in the treatment of chancroid in men. 61
6335300 1984
639
Nonsexual transmission of sexually transmitted diseases: an infrequent occurrence. 61
6610855 1984
640
Chancroidal ulcers that are not chancroid. Cause and epidemiology. 61
6326691 1984
641
Monoclonal antibodies reactive with all strains of Haemophilus ducreyi. 61
6200440 1984
642
The clinical diagnosis of genital ulcer disease in men in the tropics. 61
6611593 1984
643
Plasmid-mediated tetracycline resistance in Haemophilus ducreyi. 61
6324665 1984
644
Common beta-lactamase-specifying plasmid in Haemophilus ducreyi and Neisseria gonorrhoeae. 61
6424563 1984
645
Evaluation and management of acute genital ulcers in sexually active patients. 61
6546822 1984
646
A mixed infection of syphilis and chancroid. 61
6707258 1984
647
Herpes simplex virus in clinically suspected chancroid in Nairobi, Kenya. 61
12340182 1984
648
Comparison of media for the primary isolation of Haemophilus ducreyi. 61
6608798 1984
649
A case of mixed chancre. 61
6607850 1984
650
Therapy of chancroid with trimethoprim-sulfametrole. 61
6646193 1983
651
Epidemiology of chancroid and Haemophilus ducreyi in Nairobi, Kenya. 61
6139629 1983
652
Problems in the management of sexually transmitted diseases in South Africa. 61
6665658 1983
653
A clinical variant of chancroid resembling granuloma inguinale. 61
6639108 1983
654
Treatment of chancroid. A comparison of sulphamethoxazole and trimethoprim-sulphamethoxazole. 61
6351957 1983
655
Antimicrobial therapy of chancroid: effectiveness of erythromycin. 61
6355314 1983
656
Characterization of cell proteins of Haemophilus ducreyi by polyacrylamide gel electrophoresis. 61
6605392 1983
657
Treatment of chancroid with erythromycin. A clinical and microbiological appraisal. 61
6603249 1983
658
Single-dose therapy of chancroid with trimethoprim-sulfametrole. 61
6343878 1983
659
Short-course and single-dose antimicrobial therapy for chancroid in Kenya: studies with rifampin alone and in combination with trimethoprim. 61
6635447 1983
660
Update on chancroid. 61
6861512 1983
661
Chancroid follow-up - California. 61
6403819 1983
662
Chancroid and granuloma inguinale. 61
6687703 1983
663
[The autoinoculation test. False-positive reactions caused by herpes simplex virus]. 61
6682839 1983
664
Isolation of Haemophilus ducreyi from genital ulcerations in white men in Johannesburg. 61
6600526 1983
665
Isolation of Haemophilus ducreyi from a chancroid in Papua New Guinea. 61
6336300 1983
666
Antimicrobial therapy of chancroid: an evaluation of five treatment regimens correlated with in vitro sensitivity. 61
6601847 1983
667
Etiology of genital ulcerations in Swaziland. 61
6845114 1983
668
Chancroid in Nigeria. 61
6606880 1983
669
Treatment of chancroid. 61
6600752 1983
670
Drug of choice for chancroid. 61
6129437 1983
671
Haemophilus ducreyi infections--time for reappraisal. 61
7153512 1982
672
Single-dose thiamphenicol for chancroid. 61
6128536 1982
673
Genital ulceration in males at Ga-Rankuwa Hospital, Pretoria. 61
7147120 1982
674
Chancroid. 61
6125814 1982
675
Bacteriological study of chancroid. 61
6983497 1982
676
Treatment of chancroid by clavulanic acid with amoxycillin in patients with beta-lactamase-positive Haemophilus ducreyi infection. 61
6125676 1982
677
Isolation of Haemophilus ducreyi from patients with chancroid in Auckland. 61
7050782 1982
678
An unusual case of chancroid. 61
7094631 1982
679
Chancroid: diagnosis and treatment. 61
6978893 1982
680
Chancroid--California. 61
6804777 1982
681
Thiamphenicol in the treatment of chancroid in men. 61
7034860 1982
682
[An epidemic of chancroid. 587 cases (author's transl)]. 61
7071003 1982
683
Epidemiology of sexually transmitted diseases in the Scandinavian countries. 61
6958011 1982
684
Plasmid-mediated sulfonamide resistance in Haemophilus ducreyi. 61
6282205 1982
685
Chancroid in Sheffield. A report of 22 cases diagnosed by isolating Haemophilus ducreyi in a modified medium. 61
6976815 1981
686
Treatment of chancroid. Comparison of sulfamethoxazole-trimethoprim with recommended therapies. 61
7024580 1981
687
[Transmission of chancroid and lymphogranuloma venereum in Norway. Clinical course, diagnosis and treatment]. 61
7336406 1981
688
Molecular epidemiology of Haemophilus ducreyi infections. 61
6973943 1981
689
Treatment of chancroid with erythromycin. 61
6974899 1981
690
Sexually, transmitted disease in clinic patients in Salisbury, Zimbabwe. 61
6894561 1981
691
Treatment of chancroid with single-dose doxycycline compared with a two-day course of co-trimoxazole. 61
7027980 1981
692
Epidemiologic, clinical, laboratory, and therapeutic features of an urban outbreak of chancroid in North America. 61
6971469 1980
693
Chancroid. 61
7460616 1980
694
Giant Chancroid. 61
28218111 1980
695
[Chancroid - Diagnosis and therapy (author's transl)]. 61
7428992 1980
696
[Therapy of sexually transmissible diseases]. 61
6893380 1980
697
Some aspects of venereal diseases in Greenland. 61
6893008 1980
698
Rarer infectious diseases. 61
21293634 1980
699
Chancroid. 61
517383 1979
700
Rising incidence of chancroid in Rotterdam. Epidemiological, clinical, diagnostic, and therapeutic aspects. 61
526847 1979
701
[Diagnosis and therapy of chancroid]. 61
314204 1979
702
The treatment of chancroid: comparison of one week of sulfisoxazole with single dose doxycycline. 61
479062 1979
703
Epidemic of chancroid in Greenland 1977-78. 61
85881 1979
704
Plasmid-mediated ampicillin resistance in Haemophilus ducreyi. 61
311618 1979
705
Treatment of chancroid with Bactrim. 61
518004 1979
706
Sexually transmitted diseases: granuloma inguinale, lymphogranuloma venereum, chancroid, and infectious syphilis. 61
737918 1978
707
Ulcerative vaginitis due to Torulopsis glabrata: a case report. 61
569709 1978
708
Ultrastructural detection of Haemophilus ducreyi in biopsies of chancroid. 61
310659 1978
709
Antimicrobial susceptibility of Haemophilus ducreyi. 61
307364 1978
710
The variability of syphilitic chancres. 61
10328035 1978
711
Comparison of specimen collection and laboratory techniques for isolation of Haemophilus ducreyi. 61
342538 1978
712
The microbiological flora of penile ulcerations. 61
203634 1978
713
How suitable are available pharmaceuticals for the treatment of sexually transmitted diseases? (2) Conditions presenting as sores or tumours. 61
580068 1977
714
A case of chancroid. 61
887039 1977
715
[Chancroid]. 61
996395 1976
716
Epidemiological and clinical patterns of genital lesions. 61
989480 1976
717
The situation in Scandinavia. 61
946782 1976
718
[Lymphogranuloma venereum (LGV). Biological diagnosis]. 61
802791 1976
719
Chancroid: alias the soft chancre. 61
1092626 1975
720
Pathogenesis of Trypanosoma equiperdum in rabbits. 61
1092229 1975
721
[Chancroid in Finland]. 61
1212929 1975
722
Experience with doxycycline (Vibramycin) in the treatment of chancroid. 61
4830285 1974
723
[Case of secondary recent syphilis with extragenital chancroid]. 61
4767964 1973
724
Chancroid. 61
4635617 1972
725
The management of resistant chancroid in Vietnam. 61
4537134 1972
726
Clinical manifestations of chancroid. 61
5491929 1970
727
Simplified laboratory technique for diagnosis of chancroid. 61
4914265 1970
728
[Disappearance of chancroid in Algeria]. 61
5453956 1970
729
Treatment of chancroid. A comparison of tetracycline and sulfisoxazole. 61
5350417 1969
730
[CUTANEOUS CHANCROID PRIMARY COMPLEX IN DEEP MYCOSES]. 61
14270587 1965
731
Lederkyn in Chancroid. 61
29244404 1964
732
[USE OF LAURYL SULFATE OF THE PROPIONIC ESTER OF ERYTHROMYCIN IN THE ORAL TREATMENT OF EARLY SYPHILIS AND OF CHANCROID]. 61
14125656 1963
733
The treatment of chancroid. 61
14000783 1963
734
Propionyl erythromycin ester lauryl sulfate in the treatment of treponematosis and chancroid. 61
13881298 1961
735
Chancroid in the male. 61
13453119 1957
736
[Chancroid cases reported in Sweden 1946-1955]. 61
13422289 1957
737
Intramuscular oxytetracycline (terramycin) in the treatment of chancroid, lymphogranuloma venereum, and granuloma inguinale. 61
13363371 1956
738
V.D.R.L. chancroid studies. I. A simple procedure for the isolation and identification of Hemophilus ducreyi. 61
13332285 1956
739
V.D.R.L. chancroid studies. III. Use of Ducrey skin test vaccines on rabbits. 61
13332287 1956
740
Role of the hyperimmune reaction in chancroid; effect of ACTH. 61
13312156 1956
741
V.D.R.L. chancroid studies. II. Experimental chancroid in the rabbit. 61
13332286 1956
742
VDRL chancroid studies. IV. Experimental chancroid, prophylaxis and treatment. 61
13292899 1956
743
The importance of chancroid in Africa. 61
13307643 1956
744
[Sulfisoxazole (gantrisin) in therapy of chancroid]. 61
14391856 1954
745
Chemotherapy of chancroid; clinical observations in eighty-seven cases. 61
13189046 1954
746
The treatment of chancroid infection; a report of twenty-five cases. 61
13158757 1954
747
[Chancroid of upper lip mucosa]. 61
13219536 1954
748
[Streptomycin in the treatment of simple chancroid; attempt at treatment with dihydrostreptomycin]. 61
13051310 1953
749
Chemotherapy in chancroid. 61
13012365 1952
750
[Chancroid]. 61
13021722 1952
751
Chancroid; a report of 1,402 cases. 61
14952691 1952
752
[Treatment of chancroid and its complications with weak doses of didromycine]. 61
12987993 1952
753
The Ito skin test for chancroid in the adult and juvenile African. 61
14924082 1952
754
Experimental chancroid in man; relative effectiveness of various drugs tested by three methods. 61
14911434 1952
755
Terramycin in the treatment of chancroid, lymphogranuloma venereum, and granuloma inguinale. 61
14878094 1951
756
The treatment of granuloma inguinale, lymphogranuloma venereum, chancroid, and gonorrhea. 61
14867823 1951
757
Chancroid in Africa. 61
14862634 1951
758
[Chancroid therapy by streptomycin]. 61
14864385 1951
759
[Aureomycin in primary syphilis and chancroid]. 61
13031103 1951
760
Aureomycin and chloramphenicol in chancroid. 61
14821463 1951
761
[Streptomycin therapy of chancroid and its ganglial complications]. 61
14862449 1951
762
Chancroid in tropical Africa: Southern Rhodesia and the Gold Coast. 61
14859082 1951
763
Specificity of skin tests in lymphogranuloma venereum and chancroid. 61
14837647 1951
764
[Chancroid on the labium minus with autoinoculation on the skin of the abdomen]. 61
14879541 1951
765
[Lipogranuloma of the thigh following injection of oil of camphor with an atypical inflammatory proliferation of the epithelium resembling chancroid]. 61
14849263 1951
766
Present day treatment of chancroid, lymphogranuloma venereum, and granuloma inguinale. 61
14798879 1950
767
The use of streptomycin in the treatment of chancroid. 61
14796055 1950
768
[Treatment of chancroid by streptomycin]. 61
14790357 1950
769
[Treatment of Ducrey chancroid with local application of streptomycin]. 61
14774044 1950
770
[Treatment of a chancroid with streptomycin]. 61
15423002 1950
771
[New treatment of the minor venereal diseases: chancroid Nicolas-Favre disease and granuloma inguinal]. 61
15430070 1950
772
Aureomycin in the treatment of chancroid; a report of three cases. 61
15398709 1950
773
Oral aureomycin therapy for chancroid; report of case. 61
18128819 1949
774
The treatment of chancroid with streptomycin. 61
18124485 1949
775
Streptomycin therapy in a case of sulfonamide-resistant Hemophilus ducreyi (chancroid) infection. 61
18129457 1949
776
Chancroid, lymphogranuloma venereum and granuloma inguinale; diagnosis and treatment. 61
18890476 1948
777
Studies in the laboratory diagnosis of chancroid disease; preliminary report. 61
18881809 1948
778
Streptomycin therapy for chancroid. 61
18888072 1948
779
Treatment of chancroid with streptomycin. 61
18901058 1948
780
Chancroid in women in Manila. 61
20240336 1947
781
Diagnosis and treatment of chancroid, lymphopathia venereum, and granuloma inguinale. 61
20293100 1947
782
Evaluation of the Ducrey skin test for chancroid. 61
20281488 1947
783
Streptomycin in experimental chancroid. 61
20281481 1947
784
Chancroid? 61
21065260 1946
785
Penicillin in chancroid. 61
20282759 1946
786
Chancroid disease and its treatment. 61
20993881 1946
787
Chancroid of the uterine cervix. 61
20992954 1946
788
Observations on chancroid therapy with and without sulfathiazole. 61
20992352 1946
789
Sulfathiazole prophylaxis for gonorrhea and chancroid among soldiers in the Caribbean area. 61
20992353 1946
790
The clinical and laboratory differentiation between chancroid and lymphogranuloma venereum. 61
20984465 1946
791
The histologic diagnosis of chancroid and lymphogranuloma venereum as seen in specimens for biopsy from genital lesions. 61
21066816 1946
792
Penicillin in chancroid ulcers of pudenda. 61
20992831 1946
793
Studies on chancroid; Ducrey skin reactions in Negro hospital patients. 61
21024752 1946
794
Studies on chancroid; observations on the histology with an evaluation of biopsy as a diagnostic procedure. 61
21018106 1946
795
Studies on Chancroid: I. Observations on the Histology with an Evaluation of Biopsy as a Diagnostic Procedure. 61
19970872 1946
796
Studies on chancroid; the Ducrey bacillus; growth requirements and inhibition by antibiotic agents. 61
21013803 1946
797
Observations on chancroid therapy with and without sulfathiazole. 61
21016708 1946
798
Diagnosis of chancroid; the relative efficiency of biopsies, cultures, smears, autoinoculations and skin tests. 61
21003732 1945
799
Studies on chancroid; efficiency of the cultural method of diagnosis. 61
21005458 1945
800
The significance of immunologic tests in lymphogranuloma venereum and chancroid. 61
20275632 1945
801
Chancroid; granuloma inguinale; clinical and laboratory aspects epidemiology, and treatment. 61
20292085 1945
802
IMMUNOLOGIC RELATIONSHIP OF DONOVANIA GRANULOMATIS TO GRANULOMA INGUINALE. 61
19871442 1945
803
An Epidemic of Chancroid. 61
20322831 1943
804
Laboratory Aspects of Chancroid, Granuloma Inguinale and Lymphogranuloma Venereum. 61
18015247 1940
805
TREATMENT OF CHANCROID WITH SULPHANILAMIDE. 61
20781468 1938
806
Case of Chancroid of a Finger. 61
21773576 1935
807
Observations on the Distribution and Culture of the Chancroid Bacillus. 61
19971543 1903
808
THE ETIOLOGY OF THE CHANCROID. 61
19971344 1900

Variations for Chancroid

Expression for Chancroid

Search GEO for disease gene expression data for Chancroid.

Pathways for Chancroid

Pathways related to Chancroid according to GeneCards Suite gene sharing:

(showing 5, show less)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.94 VTN CD36 CCR6 CCR5 CCR10 CCL27
2
Show member pathways
12.88 CD40LG CD4 CCR6 CCR5 CCR10 CCL27
3
Show member pathways
12.7 CD40LG CD4 CCR6 CCR5 CCR10 CCL27
4
Show member pathways
12.11 CD4 CCR6 CCR5 CCR10 CCL27
5
Show member pathways
11.36 CCR6 CCR5 CCR10 CCL27 ACKR2

GO Terms for Chancroid

Cellular components related to Chancroid according to GeneCards Suite gene sharing:

(showing 4, show less)
# Name GO ID Score Top Affiliating Genes
1 cell GO:0005623 9.73 CD4 CD36 CCR6 CCR5 CCR10 ACKR2
2 integral component of plasma membrane GO:0005887 9.7 CD40LG CD4 CD36 CCR6 CCR5 CCR10
3 cell surface GO:0009986 9.5 HSPD1 CD40LG CD4 CD36 CCR6 CCR5
4 external side of plasma membrane GO:0009897 9.17 CD40LG CD4 CD36 CCR6 CCR5 CCR10

Biological processes related to Chancroid according to GeneCards Suite gene sharing:

(showing 13, show less)
# Name GO ID Score Top Affiliating Genes
1 calcium-mediated signaling GO:0019722 9.67 CCR6 CCR5 CCR10 ACKR2
2 positive regulation of peptidyl-tyrosine phosphorylation GO:0050731 9.65 VTN CD4 CD36
3 chemotaxis GO:0006935 9.65 CCR6 CCR5 CCR10 CCL27 ACKR2
4 chemokine-mediated signaling pathway GO:0070098 9.62 CCR6 CCR5 CCR10 ACKR2
5 positive regulation of interleukin-12 production GO:0032735 9.58 HSPD1 CD40LG CD36
6 positive regulation of cytosolic calcium ion concentration GO:0007204 9.55 CD36 CCR6 CCR5 CCR10 ACKR2
7 positive regulation of interleukin-10 production GO:0032733 9.52 HSPD1 CD40LG
8 positive regulation of T cell activation GO:0050870 9.51 HSPD1 CD4
9 dendritic cell chemotaxis GO:0002407 9.49 CCR6 CCR5
10 fusion of virus membrane with host plasma membrane GO:0019064 9.46 CD4 CCR5
11 entry into host cell GO:0030260 9.43 CD4 CCR5
12 cell chemotaxis GO:0060326 9.35 CCR6 CCR5 CCR10 CCL27 ACKR2
13 immune response GO:0006955 9.28 VTN CD40LG CD4 CD36 CCR6 CCR5

Molecular functions related to Chancroid according to GeneCards Suite gene sharing:

(showing 6, show less)
# Name GO ID Score Top Affiliating Genes
1 chemokine binding GO:0019956 9.56 CCR6 CCR5 CCR10 ACKR2
2 scavenger receptor activity GO:0005044 9.5 VTN CD36 ACKR2
3 C-C chemokine binding GO:0019957 9.46 CCR6 CCR5 CCR10 ACKR2
4 high-density lipoprotein particle binding GO:0008035 9.37 HSPD1 CD36
5 C-C chemokine receptor activity GO:0016493 9.26 CCR6 CCR5 CCR10 ACKR2
6 chemokine receptor activity GO:0004950 8.92 CCR6 CCR5 CCR10 ACKR2

Sources for Chancroid

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed